1. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009; 40: 2276 - 2293.

2. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44: 2064 - 2089.

3. Dohmen C. Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction. Stroke 2007; 38: 56 - 61.

4. Hacke W. Malignant middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol 1996; 53: 309 - 315.

5. Верещагин Н.В., Пирадов М.А. Интенсивная терапия острых нарушений мозгового кровообращения // Медицинская газета. - 1999. - N 43. - C. 2 - 3.

6. Andoh T, Sakai N, Yamada H, Hattori T, Miwa Y, Hirata T, Tanabe Y, Ohkuma A, Funakoshi T, Takada M. Cerebellar infarction: analysis of 33 cases. // Stroke. - 1987. - Vol. 18(5). - P. 849 - 855.

7. Koh M, Phan T, Atkinson J, Wijdicks E. Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect // Stroke. - 2000. - Vol.31. - P. 2062 - 2067.

8. Sypert G, Alvord E. Cerebellar infarction. A clinicopathological study //. Acta Neurochir (Wien). - 1984. - Vol. 71(3). - P. 295 - 306.

9. E. Bandera, M. Botteri, Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke. A Systematic Review. Stroke. 2006; 37: 1334 - 1339.

10. Smith, Wade S.; Johnston, S. Claiborne; Hemphill, III, J. Claude (2019). "Cerebrovascular Diseases". In Jameson, J. Larry; Fauci, Anthony S.; Kasper, Dennis L.; Hauser, Stephen L.; Longo, Dan L.; Loscalzo, Joseph (eds.). Harrisons Principles of Internal Medicine (20th ed.)

11. Гусев Е.И., Скворцова В.И. Ишемия головного мозга, М.: Медицина, 2001. - 328 с.

12. Zhang XH, Liang HM. Systematic review with network meta-analysis: Diagnostic values of ultrasonography, computed tomography, and magnetic resonance imaging in patients with ischemic stroke. Medicine (Baltimore). 2019 Jul;98(30):e16360. doi: 10.1097/MD.0000000000016360. PMID: 31348236; PMCID: PMC6709059.

13. Provost C, Soudant M, Legrand L, Ben Hassen W, Xie Y, Soize S, Bourcier R, Benzakoun J, Edjlali M, Boulouis G, Raoult H, Guillemin F, Naggara O, Bracard S, Oppenheim C. Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke. Stroke. 2019 Mar; 50(3): 659 - 664. doi: 10.1161/STROKEAHA.118.023882. PMID: 30744542.

14. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 6;363(9411):768-74. doi: 10.1016/S0140-6736(04) 15692-4. PMID: 15016487.

15. Evolving Paradigms in Neuroimaging of the Ischemic Penumbra Chelsea S. Kidwell, MD; Jeffry R. Alger, PhD; Jeffrey L. Saver, MD, Stroke.2004;35[suppl I]: 2662 - 2665.

16. H.S. Markus. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 2004;75: 353 - 361.

17. Liebeskind DS, E, Shapovalov Y, Yegin A, Landen J, Jauch EC. Cerebral Edema Associated With Large Hemispheric Infarction. Stroke. 2019; 50(9): 2619. Epub 2019 Aug 20.

18. Крылов В.В., Никитин А.С., Дашьян В.Г., Буров С.А., Петриков С.С., Асратян С.А. Хирургия массивного ишемического инсульта. - М.: ГЭОТАР-Медиа, 2016.

19. Wijdicks E., Diringer M. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin. Proc 1998;. 73(9): 829 - 836.

20. Schwab S, Aschoff A, Spranger M, Albert F, Hacke W. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology. 1996;47(2): 393.

21. Никитин А.С., Крылов В.В., Буров С.А., Петриков С.С., Асратян С.А., Камчатнов П.Р., Кемеж Ю.В., Белков М.В., Завалишин Е.Е. Дислокационный синдром у больных со злокачественным течением массивного ишемического инсульта. Журнал неврологии и психиатрии имени С.С. Корсакова 2015; 3 Спецвыпуск "Инсульт": 20 - 26.

22. Qureshi A.I., Suarez J., Yahia A.M. et al. Timing of neurological deterioration in massive middle cerebral artery infarction: a multicenter review. Crit. Care Med 2003; 31: 272 - 277.

23. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(4): 1158. Epub 2011 Feb 3.

24. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F. Cerebral vein and dural sinus thrombosis in Portugal: 1980 - 1998. Cerebrovasc Dis. 2001; 11(3): 177.

25. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012 Dec;43(12):3375-7. Epub 2012 Sep 20.

26. Coutinho JM, Ferro JM, P, Barinagarrementeria F, C, Bousser MG, Stam J. Cerebral venous and sinus thrombosis in women. Stroke. 2009; 40(7): 2356. Epub 2009 May 28.

27. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005; 352(17): 1791.

28. Gotoh M, Ohmoto T, Kuyama H. Experimental study of venous circulatory disturbance by dural sinus occlusion. ActaNeurochir (Wien). 1993; 124(2-4): 120.

29. Медико-демографические показатели Российской Федерации в 2012 году` 2013: Стат. справочник/Минздрав России. - М., 2013. - 180 c.

30. Стаховская Л.В., Клочихина О.А., Богатырева М.Д., Чугунова С.А. Анализ эпидемиологических показателей повторных инсультов в регионах Российской Федерации (по итогам территориально-популяционного регистра 2009 - 2014 гг.). Consilium Medicum. 2016; 18 (9): 8 - 11.

31. Стаховская Л.В., Ключихина О.А., Богатырева М.Д., Коваленко В.В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009 - 2010). Журнал неврологии и психиатрии, 2013, N 5, с. 4 - 10.

32. Petty G.W., Brown R.D. et al. Ischemic Stroke Subtypes A Population-Based Study of Functional Outcome, Survival, and Recurrence. Stroke. 2000; 31: 1062.

33. Никитин А.С., Асратян С.А., Смирнов Д.С., Кемеж Ю.В., Урванцева О.М. Распространенность массивного ишемического инсульта в отдельном региональном сосудистом центре. Неврологический журнал. 2017. Т. 22. N 1. С. 33 - 36.

34. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009; 40(4): 1195. Epub 2009 Feb 26.

35. Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, Olsson T. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke. 1997; 28(9): 1702.

36. Leys D, Bandu L, H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002; 59(1): 26.

37. Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol. 2013 Jan;70(1):51-7.

38. Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997; 28: 280.

39. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509.

40. Davie CA, OBrien P. Stroke and pregnancy. J Neurol Neurosurg Psychiatry 2008; 79:240.

41. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31:1274.

42. Miller EC, Gallo M, Kulick ER, et al. Infections and Risk of Peripartum Stroke During Delivery Admissions. Stroke 2018; 49:1129.

43. Ackerson T, Adeoye OM, Brown M, et al. AHA/ASA Guideline 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke; 2018. doi:10.1161/STR.0000000000000158.

44. Wabnitz A, Bushnell C. Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. Cephalalgia 2015; 35:132.

45. Adams H, Bendixen B, Kappelle J et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993; 24; 1: 35 - 40.

46. Robert G. Hart, Luciana Catanese, Kanjana S. Perera, George Ntaios, Stuart J. Connolly. Embolic Stroke of Undetermined Source A Systematic Review and Clinical Update. Stroke. 2017; 48: 867 - 872.

47. Amarenco P., Kase C., Rosengart A. et al. Very small (border zone) cerebellar infarcts, distribution, causes, mechanisms and clinical features // Brain. - 1993. - Vol. 116. - N. 1. - P. 161 - 186.

48. Bussaka H., Sakamoto Y., Hatanaka Y. et al. Cerebellar infarction; the findings of CT, MRI and cerebral angiography // Rinsho Hoshasen. - 1990. - Vol. 35. - N. 4. - P. 445 - 451.

49. Milandre L., Brosset C., Gouirand R., Khalil R. Pure cerebellar infarction. Thirty cases. Presse Med. 1992 Oct 10; 21(33): 1562-5.

50. Kase C., Norrving B., Levine S. et al. Cerebellar infarction. Clinical and anatomic observation in 66 cases // Stroke. - 1993. - Vol. 24. - P. 76 - 83.

51. Lee H., Sohn S., Jung D. et al. Sudden deafness and anterior inferior cerebellar artery infarction // Stroke. - 2002. - Vol. 33. - P. 2807 - 2812.

52. Hornig C., Rust D., Busse O. et al. Space-occupying cerebellar infarction. Clinical course and prognosis // Stroke. - 1994. - Vol. 25. - N. 2. - P. 372 - 374.

53. Czernicki T., Marchel A. Results of treatment of cerebellar infarctions //Neurol Neurochir Pol. - 2004. - Vol. 38. - N. 1. - P. 37 - 43.

54. Greenberg J., Skubick D., Shenkin H. Acute hydrocephalus in cerebellar infarct and hemorrhage // Neurology. - 1979. - Vol. 29. - P. 409 - 413.

55. Khan M., Polyzoidis K., Adegbite A., McQueen J. Massive cerebellar infarction: conservative management // Stroke. - 1983. - Vol. 14. - P. 745 - 751.

56. Cuneo R., Caronna J., Pitts L. et al. Upward transtentorial herniation: seven cases and a literature review // Arch Neurol. - 1979. - Vol. 36. - N. 10. - P. 618 - 623.

57. Yamazaki M., Hashimoto T., Haruta S., Yanagisawa N. A case of transtentorial upward herniation due to cerebellar infarction manifesting upward gaze palsy as an initial sign // No To Shinkei. - 1993. - Vol. 45. - N. 2. - P. 183 - 187.

58. Ferro JM, P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35(3): 664. Epub 2004 Feb 19.

59. Gregson JM, Leathley MJ, Moore AP, Smith TL, Sharma AK, Watkins CL. Reliability of measurements of muscle tone and muscle power in stroke patients. Age Ageing. 2000 May; 29(3):223-8. doi: 10.1093/ageing/29.3.223. PMID: 10855904. Интернетресурс: https://pubmed.ncbi.nlm.nih.gov/10855904.

60. Рекомендации по ведению больных с острым нарушением мозгового кровообращения Американской ассоциации сердца (AHA) и Американской ассоциации по борьбе с инсультами (АSA) 2005. Stroke 2005; 36; 916 - 923. Интернет-ресурс: http://stroke.ahajournals.ord/content/36/4/916.e[tract].

61. Tsao JW, Hemphill JC 3rd, Johnston SC, Smith WS, Bonovich DC. Initial Glasgow Coma Scale score predicts outcome following thrombolysis for posterior circulation stroke. Arch Neurol. 2005 Jul;62(7):1126-9. doi: 10.1001/archneur.62.7.1126. PMID: 16009770. Интернетресурс: https://pubmed.ncbi.nlm.nih.gov/16009770.

62. Van Wijngaarden JD, Dirks M, Huijsman R, Niessen LW, Fabbricotti IN, Dippel DW; Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE) Investigators. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture. Stroke. 2009 Oct; 40(10): 3390-2.

63. Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk B, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44: 870 - 947.

64. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46: 000-000.

65. IST-3 Collaborative Group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol. 2015; 14: 485 - 496.

66. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR; NINDS rt-PA Stroke Study Group. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis. 2008; 26: 120 - 125.doi: 10.1159/000139658.

67. Dzialowski I, Hill MD, Coutts SB, Demchuk AM, Kent DM, Wunderlich O, von Kummer R. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006; 37: 973 - 978. doi: 10.1161/01.STR.0000206215.62441.56.

68. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999 Dec 1;282(21):2003-11.

69. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Divani AA. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology. 2006; 66: 1171 - 1174. doi: 10.1212/01.wnl.0000208407.69544.5a.

70. Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group. Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke. Neurology. 2016; 86: 118 - 125. doi: 10.1212/WNL.0000000000002236.

71. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006; 60: 508 - 517. doi:10.1002/ana.20976.

72. Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, Ford I, Muir KW. Alteplase Versus Tenecteplase for Thrombolysis After Ischaemic Stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015; 14: 368 - 376. doi:10.1016/S1474-4422(15)70017-7.

73. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014:CD000213.

74. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O'Brien B, Bladin C, McElduff P, Allen C, Bateman G, Donnan G, Davis S, Levi C. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012; 366: 1099 - 1107. doi: 10.1056/NEJMoa1109842.

75. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, S hngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009; 8: 141 - 150. doi: 10.1016/S1474-4422(08)70267-9.

76. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM; EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7: 299 - 309. doi: 10.1016/S1474-4422(08)70044-9.

77. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W; for the DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006; 37: 1227 - 1231. doi: 10.1161/01.STR. 0000217403.66996.6d.

78. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; for the DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005; 36: 66 - 73. doi:10.1161/01.STR.0000149938.08731.2c.

79. Буров С.А., Никитин А.С., Асратян С.А., Крылов В.В. Факторы риска развития злокачественного течения обширного ишемического инсульта. Нейрохирургия 2012; 3: 18 - 25.

80. Achit H, Soudant M, Hosseini K, Bannay A, Epstein J, Bracard S, Guillemin F; THRACE Investigators. Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke: The THRACE Randomized Controlled Trial. Stroke. 2017 Oct; 48(10): 2843 - 2847. doi: 10.1161/STROKEAHA.117.017856.

81. Yu W, Jiang WJ. A Simple Imaging Guide for Endovascular Thrombectomy in Acute Ischemic Stroke: From Time Window to Perfusion Mismatch and Beyond. Front Neurol. 2019; 10: 502. Published 2019 May 24. doi:10.3389/fneur.2019.00502

82. Tsivgoulis G, Katsanos AH, Schellinger PD, M, Caso V, Palaiodimou L, Magoufis G, Arthur A, Fischer U, Alexandrov AV. Advanced Neuroimaging in Stroke Patient Selection for Mechanical Thrombectomy. Stroke. 2018 Dec; 49(12): 3067 - 3070. doi: 10.1161/STROKEAHA.118.022540. PMID: 30571421.

83. Aghaebrahim A, Jadhav AP, Hanel R, Sauvageau E, Granja MF, Zhang Y, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Ribo M, Cognard C, Sila C, Yavagal D, Hassan AE, Smith WS, Saver J, Liebeskind DS, Nogueira RG, Jovin TG; DAWN Investigators. Outcome in Direct Versus Transfer Patients in the DAWN Controlled Trial. Stroke. 2019 Aug; 50(8): 2163 - 2167. doi: 10.1161/STROKEAHA.119.025710. Epub 2019 Jul 15.

84. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018 Jan 4; 378(1): 11 - 21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.

85. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart R, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mylnash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; on behalf of the DEFUSE 3 Investigators. Thrombectomy for stroke with perfusion imaging selection at 6 - 16 hours. N Engl J Med.

86. Abdoh N. Zettervall O., Carlson J., et al. Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patients // Stroke. - 1982. - Vol. 13 - P. 832 - 837.

87. Kessler C., von Maravic M., Bruckmann H., Kompf D. Ultrasound for the assessment of the embolic risk of carotid plaques // Acta Neurol. Scand. - 1995. - Vol. 92. - P. 231 - 234.

88. Mayor I., Fossati C., Sztajzel R., Carotid plaque morphology and microembolic signals (MES): A study of 38 patients with moderate or high-grade stenosis // Cerebrovasc Dis. - 2001. - Vol. - 11, suppl. 3 - P. 26.

89. Nagatsuka K., Kajimoto K., Nagano K., et al. Relationship between microembolic signal and carotid plaque echogenesity // Cerebrovasc. Dis. - 2001. - Vol. 11, suppl. 3. - P. 26.

90. Tegos T.J., Sabetai M.M., Nicolaides A.N. et al. Correlates of embolic events detected by means of transcranial Doppler in payients with carotid atheroma // J. Vasc. Surg. - 2001. - Vol. 33. - P. 131 - 138.

91. Censori B., Partziguian T., Casto L. et al. Doppler microembolic signals predict ischemic recurrences in symptomatic carotid stenosis // Ibid. - Vol. 101. - P. 327 - 331.

92. Kaps N. Detection of embolic events by ultrasound // Stroke Prevention / Eds W. Dorndorf, P. Marx. - Basel: Karger, 1994. - P. 322 - 325.

93. Georgiadis D., Lindner A., Manz M. at al. Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls // Ibid. - 1997. - Vol. 28. - P. 1203 - 1207.

94. Molloy J., Markus H.S. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis // Stroke. - 1999. - Vol. 30. - P. 1440 - 1443.

95. Nabavi D.G., Georgiadis D., Mumme T. et al. Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices: A prospective study // Stroke. - 1996. - Vol. 27. - P. 891 - 896.

96. Rapp J.H., Pan X.M., Sharp F.R. et al. Atheroemboli to the brain Size threshold for causing acute neuronal cell death // J. Vasc. Surg. - 2000. - Vol. 32. - P. 68 - 76.

97. Valton L., Larrue V., Pavy Le Traon A., Geraud G. Cerebral microembolism in patients with stroke or transient ischaemic attack as a risk factor for early recurrence // J. Neurol. Neurosurg. Psychiatry. - 1997. - Vol. 63. - P. 784 - 787.

98. Valton L., Larrue V., Pavy Le Traon A., Microembolic signals and risk of early recurrence in patients with stroke of transient ischemic attack // Stroke. - 1998. - Vol. 29. - P. 2125 - 2128.

99. Zhu C.Z., Norris J.W. TCD - a new test for embolic stroke // Proceedings of the 6th International Symposium on Intracranial Hemodynamics. - San Diego, 1992.

100. Cujec B., Polasek P., Voll C., Shuaib A., Transesophageal electrocardiography in the detection of potential cardiac source of embolism in stroke patients // Stroke. - 1991. - Vol. 22. - P. 727 - 733.

101. De Belder M.A., Lovat L.B., Tourikis L. et al. Limitations of transesophageal electrocardiography in patients with focal cerebral ischaemic events // Br. Heart J. - 1992. - Vol. 67. - P. 297 - 303.

102. De Rook F.A., Commes K.A., Albers G.W., Popp R.L. Transesophageal electrocardiography in the evalution of stroke // Ann. Intern. Med. - 1992 - Voll. 117. - P. 922 - 932.

103. Delcker A., Diener H.C., Neurologische Diagnostik und therapeustische Massnahmen bei zerebralen Embolien // Herz. - 1991. - Jg. 16. - S. 434 - 443.

104. Espinola Zavaleta N., Vargas Barron J., Romero Cardenas A. et al. Ecocardiographia transtoracica y transesofagica en el studio de auditos jovenes con evento isquemico cerebral // Arch. Inst. Cardiol. Mex/ - 1993. - Vol. 63. - P. 311 - 316.

105. Soares Franco A., Monteiro J., Ferreira D., et al. A importancia da doenca cardiaca nos varios tipos de Acidente Vascular Cerebral: Estudo prospectivo // Rev. Port. Cardiol. - 1990. - Vol. 9. - P. 425 - 432.

106. Vital sign monitoring following stroke associated with 90-day independence: A secondary analysis of the QASC cluster randomized trial. S. Middleton, P. McElduff, P. Drury, C. DEste, D. A Cadilhac, S. Dale, J. M Grimshaw, J. Ward, C. Quinn, N W. Cheung, C. Levi. Int J Nurs. Stud. 2019 Jan; 89: 72 - 79. doi: 10.1016/j.ijnurstu.2018.09.014. Epub 2018 Sep 27.

107. Damiani E, Adrario E, Girardis M, et al. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2014; 18(6): 711. Published 2014 Dec 23. doi:10.1186/s13054-014-0711-x.

108. Langhorne P, Pollock A: What are the components of effective stroke unit care? Age Ageing 2002; 31: 365 - 371.

109. Josephson SA, Hills NK, Johnston SC. NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis. 2006; 22(5-6): 389 - 95. doi: 10.1159/000094857. Epub 2006 Aug 4. PMID: 16888381.

110. Cavallini A, Micieli G, Marcheselli S, Quaglini S. Role of monitoring in management of acute ischemic stroke patients. Stroke. 2003 Nov; 34(11): 2599 - 603. doi: 10.1161/01.STR.0000094423.34841.BB. Epub 2003 Oct 16. PMID: 14563969.

111. Borsellino B, Schultz MJ, Gama de Abreu M, Robba C, Bilotta F. Mechanical ventilation in neurocritical care patients: a systematic literature review. Expert Rev Respir Med. 2016; 10: 1123 - 32.

112. Rajajee V, Riggs B, Seder DB. Emergency neurological life support: airway, ventilation, and sedation. Neurocrit Care. 2017; 27(Suppl 1): 4 - 28.

113. Robba, C., Bonatti, G., Battaglini, D. et al. Mechanical ventilation in patients with acute ischaemic stroke: from pathophysiology to clinical practice. Crit Care 23, 388 (2019) doi:10.1186/s13054-019-2662-8.

114. Chu DK, Kim LH, Young PJ, Zamiri N, Almenawer SA, Jaeschke R, Szczeklik W, Sch nemann HJ, Neary JD, Alhazzani W. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018 Apr 28; 391(10131): 1693 - 1705. doi: 10.1016/S0140-6736(18)30479-3. Epub 2018 Apr 26. PMID: 29726345.

115. Roffe C, Nevatte T, Sim J, Bishop J, Ives N, Ferdinand P, Gray R; Stroke Oxygen Study Investigators and the Stroke Oxygen Study Collaborative Group. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the Stroke Oxygen Study Randomized Clinical Trial. JAMA. 2017; 318: 1125 - 1135.

116. Roffe C, Nevatte T, Bishop J, Sim J, Penaloza C, Jowett S, Ives N, Gray R, Ferdinand P, Muddegowda G. Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT. Health Technology Assessment. 2018; 22(14): 1 - 88.

117. Bennett MH, Weibel S, Wasiak J, Schnabel A, French C, Kranke P. Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014:CD004954.

118. Heyboer M 3rd, Sharma D, Santiago W, McCulloch N. Hyperbaric oxygen therapy: side effects defined and quantified. Adv Wound Care (New Rochelle). 2017; 6: 210 - 224.

119. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009; 8: 48 - 56. doi: 10.1016/S1474-4422(08) 70263-1.

120. He J, ZhangY, XuT, ZhaoQ, WangD, ChenCS, TongW, LiuC, XuT, JuZ, PengY, PengH, LiQ, GengD, ZhangJ, LiD, ZhangF, GuoL, SunY, WangX, CuiY, LiY, MaD, YangG, GaoY, YuanX, BazzanoLA, ChenJ; CATIS Investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA. 2014; 311: 479 - 489.doi: 10.1001/jama.2013.282543.

121. Lee M, Ovbiagele B, Hong KS, Wu YL, Lee JE, Rao NM, Feng W, Saver JL. Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke. 2015; 46: 1883 - 1889. doi: 10.1161/STROKEAHA.115.009552.

122. Stead LG, Gilmore RM, Vedula KC, Weaver AL, Decker WW, Brown RD Jr. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology. 2006; 66: 1878 - 1881. doi: 10.1212/01.wnl.0000219628.78513.b5.

123. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, Poulter NR; COSSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010; 9: 767 - 775. doi: 10.1016/S1474-4422(10)70163-0.

124. Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. 2014:CD000039.

125. Visvanathan A, Dennis M, Whiteley W. Parenteral fluid regimens for improving functional outcome in people with acute stroke. Cochrane Database Syst Rev. 2015:CD011138.

126. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG: Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000; 31: 2043 - 2048.

127. Koenig MA, Geocadin RG, de Grouchy M, Glasgow J, Vimal S, Restrepo L, Wityk RJ. Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocrit Care. 2006; 4(1): 3 - 7. doi: 10.1385/NCC:4:1:003. PMID: 16498187.

128. Lee MH, Kim JG, Jeon SB, Kang DW, Kwon SU, Kim JS. Pharmacologically Induced Hypertension Therapy for Acute Stroke Patients. J Stroke. 2019; 21(2): 228 - 230. doi:10.5853/jos.2019.00437.

129. Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, Jeerakathil T, Campbell BC, Barber PA, Bladin C, Fink J, Tress B, Donnan GA, Davis SM; for the EPITHET Investigators. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010; 41: 72 - 77.

130. Perini F, De Boni A, Marcon M, Bolgan I, Pellizzari M, Dionisio LD. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke. J Neurol Sci. 2010.

131. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N; for the SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012; 43: 1524 - 1531.

132. Waltimo T, Haapaniemi E, Surakka IL, Melkas S, Sairanen T, Sibolt G, Tatlisumak T, Strbian D. Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage. Eur J Neurol. 2016; 23: 1757 - 1762.

133. Jillella DV, Calder CS, Uchino K, Qeadan F, Ikram A, Casul YR, Tran HQ. Blood Pressure and Hospital Discharge Outcomes in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy. J Stroke Cerebrovasc Dis. 2020 Nov; 29(11): 105211. doi: 10.1016/j.jstrokecerebrovasdis.2020.105211. Epub 2020 Aug 7. PMID: 33066897.

134. Endo K, Kario K, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Namekawa M, Miyagi T, Osaki M, Minematsu K, Toyoda K. Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. Stroke. 2013; 44: 816 - 818.

135. Liu K, Yan S, Zhang S, Guo Y, Lou M. Systolic blood pressure variability is associated with severe hemorrhagic transformation in the early stage after thrombolysis. Transl Stroke Res. 2016; 7: 186 - 191.

136. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San L, Serena J, Abilleira S, , M, Urra X, Cardona P, L pez-Cancio E, Tomasello A, C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, M, Goyal M, Demchuk AM, von Kummer R, Gallofr M, A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015; 372: 2296 - 2306.

137. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnilde Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372: 2285 - 2295.

138. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372: 1019 - 1030.

139. Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F; THRACE Investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; 15: 1138 - 1147.

140. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, GJ, Boiten J, Brouwer PA, Emmer BJ, deBruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, van den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; MRCLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372: 11 - 20.

141. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372: 1009 - 1018.

142. Bath PM, Krishnan K, Appleton JP. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2017 Apr 21;4:CD000398; Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. 2014 Oct 28;(10):CD000039.

143. Bath PM. Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. Cochrane Database Syst Rev. 2004;(3):CD000211.

144. Zhang J, Liu J, Li D, Zhang C, Liu M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2019 Feb 13;2:CD001928.

145. Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg. 1992; 76(1): 91-8.

146. Ertmer C, Van Aken H. Fluid therapy in patients with brain injury: what does physiology tell us? Crit Care. 2014; 18(2): 119.

147. Chang TS, Jensen MB. Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2014, Issue 8. Art. No.: CD000103. DOI: 10.1002/14651858.CD000103.pub2.

148. van der Jagt, M. Fluid management of the neurological patient: a concise review. Crit Care 20, 126 (2016) doi:10.1186/s13054-016-1309-2/.

149. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine 2004; 350:2247-56.

150. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000 Feb; 31(2): 410-4.

151. Prasad K, Krishnan PR. Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis. Acta Neurol Scand 2010; 122:404-8.

152. Azzimondi G, Bassein L, Nonino F et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke 1995; 26:2040-3.

153. Saxena M, Young P, Pilcher D, Bailey M, Harrison D, Bellomo R, Finfer S, Beasley R, Hyam J, Menon D, Rowan K, Myburgh J. Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med. 2015; 41: 823 - 832.

154. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998; 29:2455-60; Drury P, Levi C, McInnes E et al. Management of fever, hyperglycemia, and swallowing dysfunction following hospital admission for acute stroke in New South Wales, Australia. Int J Stroke 2014; 9: 23-3.

155. Middleton S, Mc Elduff P, Ward J et al. Implementation of evidence based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): A cluster randomized controlled trial. Lancet 2011; 378: 1699-706.

156. Middleton S, Drury P, Levi CR et al.What processes of clinical care are associated with 90-day survival and independence? Results from the quality in acute stroke care QASC trial. Int J Stroke 2012; 7:25.

157. Rincon F, Hunter K, Schorr C, Dellinger RP, Zanotti-Cavazzoni S. The epidemiology of spontaneous fever and hypothermia on admission of brain injury patients to intensive care units: a multicenter cohort study. J Neurosurg. 2014 Oct; 121(4): 950-60.

158. Niven DJ, Laupland KB. Pyrexia: aetiology in the ICU. Crit Care. 2016 Sep 1; 20: 247.

159. Vermeij JD, Westendorp WF, Dippel DW, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst Rev. 2018 Jan 22; 1: CD008530.

160. Liu L, Xiong XY, Zhang Q, Fan XT, Yang QW. The Efficacy of Prophylactic Antibiotics on Post-Stroke Infections: An Updated Systematic Review and Meta-Analysis. Sci Rep. 2016 Nov 14; 6: 36656.

161. Badve MS, Zhou Z, Anderson CS, Hackett ML. Effectiveness and Safety of Antibiotics for Preventing Pneumonia and Improving Outcome after Acute Stroke: Systematic Review and Meta-analysis. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11): 3137 - 3147.

162. Westendorp WF, Vermeij JD, Zock E, Hooijenga IJ, Kruyt ND, Bosboom HJ, Kwa VI, Weisfelt M, Remmers MJ, ten Houten R, Schreuder AH, Vermeer SE, van Dijk EJ, Dippel DW, Dijkgraaf MG, Spanjaard L, Vermeulen M, van der Poll T, Prins JM, Vermeij FH, Roos YB, Kleyweg RP, Kerkhoff H, Brouwer MC, Zwinderman AH, van de Beek D, Nederkoorn PJ; PASS investigators. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015 Apr 18; 385(9977): 1519-26.

163. Kalra L, Irshad S, Hodsoll J, Simpson M, Gulliford M, Smithard D, Patel A, Rebollo-Mesa I; STROKE-INF Investigators. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet. 2015 Nov 7; 386(10006): 1835-44.

164. Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, Meyer B, Jurf J, Altafullah I, Raman R. Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke. 2016; 47: 2888 - 2895.

165. Geurts M, Petersson J, Brizzi M, Olsson-Hau S, Luijckx GJ, Algra A, Dippel DW, Kappelle LJ, van der Worp HB. COOLIST (Cooling for Ischemic Stroke Trial): a multicenter, open, randomized, phase II, clinical trial. Stroke. 2017; 48: 219 - 221.

166. van der Worp, H. B., Macleod, M. R., Bath, P. M., Bathula, R., Christensen, H., Colam, B., Schwab, S. (2019). Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial. European Stroke Journal, 4(3), 254 - 262.

167. Dippel DW, Breda EJ, Worp HB et al. Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke (PISA), a phase II double-blind, randomized, placebo-controlled trial [isrctn98608690]. BMC Cardiovasc Disord 2003; 3:2.

168. de Ridder IR, de Jong FJ, den Hertog HM et al. Paracetamol (acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 degrees c or above. Int J Stroke 2015; 10: 457-62.

169. Piironen K, Putaala J, Rosso C, et al. Glucose and acute stroke: evidence for an interlude. Stroke 2012; 43: 898 - 902.

170. Tan X, He J, Li L, et al. Early hyperglycaemia and the early-term death in patients with spontaneous intracerebral haemorrhage: A meta-analysis. Intern Med J 2014; 44: 254 - 260.

171. Saxena A, Anderson CS, Wang X, et al. Prognostic significance of hyperglycemia in acute intracerebral hemorrhage: The INTERACT2 study. Stroke 2016; 47: 682 - 688.

172. Guo X, Li H, Zhang Z, et al. Hyperglycemia and mortality risk in patients with primary intracerebral hemorrhage: a meta-analysis. Mol Neurobiol 2016; 53: 2269 - 2275.

173. Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission hyperglycemia and clinical outcome in cerebral venous thrombosis. Stroke 2016; 47: 390 - 396.

174. Fuentes, B., Ntaios, G., Putaala, J., Thomas, B., Turc, G., & , E. (2018). European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. European Stroke Journal, 3(1), 5-21.

175. Ntaios G, Egli M, Faouzi M, Michel P. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke. 2010 Oct; 41(10): 2366-70.

176. Benfield JK, Everton LF, Bath PM, England TJ. Accuracy and clinical utility of comprehensive dysphagia screening assessments in acute stroke: A systematic review and meta-analysis. J Clin Nurs. 2020 May; 29(9-10): 1527 - 1538. doi: 10.1111/jocn.15192. Epub 2020 Feb 11. PMID: 31970825.

177. Joundi RA, Martino R, Saposnik G, Giannakeas V, Fang J, Kapral MK. Predictors and outcomes of dysphagia screening after acute ischemic stroke. Stroke. 2017; 48: 900 - 906.

178. Dennis M, Lewis S, Cranswick G, Forbes J; FOOD Trial Collaboration. FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess. 2006; 10: iii-iv, ix.

179. Geeganage C, Beavan J, Ellender S, Bath PM. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012; 10: CD000323.

180. RT, Rasmussen RS, Overgaard K, Lerche A, Johansen AM, Lindhardt T. Dysphagia screening and intensified oral hygiene reduce pneumonia after stroke. J Neurosci Nurs. 2013; 45: 139 - 146.

181. Brady M, Furlanetto D, Hunter RV, Lewis S, Milne V. Staff-led interventions for improving oral hygiene in patients following stroke.

182. Cochrane Database Syst Rev. 2006: CD003864; Wagner C, Marchina S, Deveau JA, Frayne C, Sulmonte K, Kumar S. Risk of stroke-associated pneumonia and oral hygiene. Cerebrovasc Dis. 2016; 41: 35 - 39.

183. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PAG. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD001922.

184. Dennis M, Caso V, Kappelle LJ, Pavlovic A, Sandercock P. European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J. 2016; 1: 6 - 19.

185. Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013; 382: 516 - 524.

186. Sandercock PA, Leong TS. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev 2017; 4:CD000119.

187. Shorr AF, Jackson WL, Sherner JH, Moores LK. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis. Chest 2008; 133: 149.

188. Paciaroni M, Agnelli G, Venti M, et al. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost 2011; 9: 893.

189. John G, Bardini C, P, Combescure C, P. Urinary incontinence as a predictor of death after new-onset stroke: a meta-analysis. Eur J Neurol. 2016 Oct; 23(10): 1548-55. doi: 10.1111/ene.13077. Epub 2016 Jul 18. PMID: 27425212.

190. Европейско-азиатские рекомендации по ведению пациентов с инфекциями, связанными с уретральными катетерами, и по профилактике катетер-ассоциированных инфекций, 2008. Стр.: 83 - 91.

191. Рекомендации Европейской ассоциации урологов (EAU), Урологической ассоциации Азии (UAA) // Клиническая микробиология и антимикробная химиотерапия, 2008, том 10, N 3.

192. Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun; 47(6): e98-e169. doi: 10.1161/STR.0000000000000098. Epub 2016 May 4. Erratum in: Stroke. 2017 Feb; 48(2): e78. Erratumin: Stroke. 2017 Dec; 48(12): e369. PMID: 27145936.

193. Рекомендации по профилактике инсульта у пациентов с инсультом или транзиторной ишемической атакой Американской ассоциации сердца (AHA) и Американской ассоциации по борьбе с инсультами (АSA) 20010 Stroke 2011; 42: 226 - 227.

194. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar; 49(3): e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24.

195. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998; 29: 1888 - 1893.

196. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ, Wintermark M; on behalf of the American Heart Association Stroke Council. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 1222 - 1238. doi: 10.1161/01.str.0000441965.15164.d6.

197. Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010; 38: 1348 - 1359.

198. Wan YH, Nie C, Wang HL, Huang CY. Therapeutic hypothermia (different depths, durations, and rewarming speeds) for acute ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis. 2014; 23: 2736 - 2747.

199. Quizilbash N, Lewington SL, Lopez-arietta J. Corticosteroids for acute ischemic stroke. Cochrane library. Oxford (United Kingdom): Update software. - 2001 (1).

200. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012 Jun 23; 379(9834): 2364-72.

201. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363: 768 - 774. doi: 10.1016/S0140-6736(04)15692-4.

202. Шамалов Н.А., Хасанова Д.Р., Стаховская Л.В., Вознюк И.А., Янишевский С.Н., Виноградов О.И., Харитонова Т.В., Алекян Б.Г., Кандыба Д.В., Савелло А.В. Реперфузионная терапия ишемического инсульта. Клинический протокол. М., 2019. - 80 с.

203. Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, Hershey LA, Qazi KJ; Buffalo Metropolitan Area and Erie County Stroke Study Group. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology. 2005; 64: 2115 - 2120.

204. Wahlgren N, Ahmed N, A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet. 2007; 369: 275 - 282.

205. Wardlaw JM, Sandercock PA, Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke. 2003; 34: 1437 - 1442.

206. Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005; 172: 1307 - 1312.

207. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Zhao X, Olson DM, Schwamm LH; GWTG-Stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010; 41: 1431 - 1439.

208. Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE; on behalf of the American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2016; 47: e262]. Stroke. 2016; 47: 581 - 641. doi: 10.1161/STR.0000000000000086.

209. IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet. 2012; 379: 2352 - 2363.

210. Hacke W, Kaste M, Bluhmki E, Brozman M, A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317 - 1329. doi: 10.1056/NEJMoa0804656.

211. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; on behalf of the Stroke Thrombolysis Trialists' Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016; 47: 2373 - 2379. doi: 10.1161/STROKEAHA.116.013644.

212. Anderson CS. N Engl J Med 2016; 374: 2313 - 2323 June 16, 2016 DOI: 10.1056/NEJMoa1515510.

213. Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, VV, Demchuk AM, Bath PM, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Ricci S, Roffe C, Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, Chalmers J; ENCHANTED Investigators and Coordinators. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med. 2016; 374: 2313 - 2323.

214. Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, Tobro H, Kaur K, Stankiewicz M, Carlsson M, , Idicula T, Aamodt AH, Lund C, H, Waje-Andreassen U, Thomassen L. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017 Oct; 16(10): 781 - 788.

215. Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, M, Guibernau J, KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C; WAKE-UP Investigators. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med. 2018 Aug 16; 379(7): 611 - 622.

216. Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology. 1995; 45: 649 - 658.

217. Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial: Global Utilization of Streptokinase and Tissue-Plasminogen Activator (tPA) for Occluded Coronary Arteries. Am Heart J. 1999; 138(pt 1): 493 - 499.

218. Goldstein JN, Marrero M, Masrur S, Pervez M, Barrocas AM, Abdullah A, Oleinik A, Rosand J, Smith EE, Dzik WH, Schwamm LH. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol. 2010; 67: 965 - 969. doi: 10.1001/archneurol.2010.175.

219. French KF, White J, Hoesch RE. Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator. Neurocrit Care. 2012; 17: 107 - 111. doi: 10.1007/s12028-012-9681-5.

220. Yaghi S, Eisenberger A, Willey JZ. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol. 2014; 71: 1181 - 1185. doi: 10.1001/jamaneurol.2014.1210.

221. Yaghi S, Haggiagi A, Sherzai A, Marshall RS, Agarwal S. Use of recombinant factor VIIa in symptomatic intracerebral hemorrhage following intravenous thrombolysis. Clin Pract. 2015; 5: 756. doi: 10.4081/cp.2015.756.

222. Yaghi S, Boehme AK, Dibu J, Leon Guerrero CR, Ali S, Martin-Schild S, Sands KA, Noorian AR, Blum CA, Chaudhary S, Schwamm LH, Liebeskind DS, Marshall RS, Willey JZ. Treatment and outcome of thrombolysis-related hemorrhage: a multicenter retrospective study. JAMA Neurol. 2015; 72: 1451 - 1457. doi: 10.1001/jamaneurol.2015.2371.

223. Foster-Goldman A, McCarthy D. Angioedema from recombinant TPA administration: case report and pathophysiology review. Am J Ther. 2013; 20: 691 - 693. doi: 10.1097/MJT.0b013e3182799083.

224. Gorski EM, Schmidt MJ. Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke. J Emerg Med. 2013; 45: e25 - e26. doi: 10.1016/j.jemermed.2013.02.004.

225. Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013; 45: 789 - 796. doi: 10.1016/j.jemermed.2013.03.045.

226. Lin SY, Tang SC, Tsai LK, Yeh SJ, Hsiao YJ, Chen YW, Chen KH, Yip BS, Shen LJ, Wu FL, Jeng JS. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use. Eur J Neurol. 2014; 21: 1285 - 1291. doi: 10.1111/ene.12472.

227. Correia AS, Matias G, Calado S, A, Viana-Baptista M. Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal. J Stroke Cerebrovasc Dis. 2015; 24: 31 - 40. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.045. Pahs L, Droege C, Kneale H, Pancioli A. A novel approach to the treatment of orolingual angioedema after tissue plasminogen activator administration. Ann Emerg Med. 2016; 68: 345 - 348. doi: 10.1016/j.annemergmed.2016.02.019.

228. Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ, Lee SH. Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment. Neurology. 2016; 87: 996 - 1002.

229. Hankey GJ, Norrving B, Hacke W, Steiner T. Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke. 2014 Jul; 9(5): 627-32. doi: 10.1111/ijs.12295. Epub 2014 Jun 2.

230. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P; European Heart Rhythm Association. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013 May; 15(5): 625-51. doi: 10.1093/europace/eut083.

231. Pikija S, Sztriha LK, Sebastian Mutzenbach J, Golaszewski SM, Sellner J. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence. CNS Drugs. 2017 Sep; 31(9): 747 - 757. doi: 10.1007/s40263-017-0460-x.

232. Kermer P, Eschenfelder CC, Diener HC et al Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection. Int J Stroke. 2017 Jun; 12(4): 383 - 391. doi: 10.1177/1747493017701944. Epub 2017 Mar 24.

233. D, Jakub ek S, ern k D Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9): 2479 - 2483. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.004. Epub 2018 May 25.

234. Pollack CV Jr, Reilly PA, van Ryn J et al Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 Aug 3; 377(5): 431 - 441. doi: 10.1056/NEJMoa1707278. Epub 2017 Jul 11.

235. Reilly PA1, van Ryn J2, Grottke O3, Glund S4, Stangier J4. Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects.

236. Goyal, M., et al., Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet, 2016. 387(10029): p. 1723 - 31.

237. Touma, L., et al., Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Neurol, 2016

238. Badhiwala, J.H., et al., Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA, 2015. 314(17): p. 1832 - 43.

239. Saver, J.L., et al., Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA, 2016. 316(12): p. 1279-88.

240. Emberson, J., et al., Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet, 2014. 384(9958): p. 1929 - 35.

241. Lees, K.R., et al., Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke, 2016. 47(9): p. 2373 - 9.

242. Campbell, B.C.V., et al., Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. The Lancet Neurology, 2019. 18(1): p. 46 - 55.

243. Barral, M., et al., Stent retriever thrombectomy for acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials, including THRACE. Rev Neurol (Paris), 2018. 174(5): p. 319 - 326.

244. Primiani, C.T., et al., Direct Aspiration versus Stent Retriever Thrombectomy for Acute Stroke: A Systematic Review and Meta-Analysis in 9127 Patients. J Stroke Cerebrovasc Dis, 2019. 28(5): p. 1329 - 1337.

245. Boulanger, M., et al., First-line contact aspiration vs stent-retriever thrombectomy in acute ischemic stroke patients with large-artery occlusion in the anterior circulation: Systematic review and meta-analysis. Interv Neuroradiol, 2019. 25(3): p. 244 - 253.

246. Qin, C., et al., Efficacy and safety of direct aspiration versus stent-retriever for recanalization in acute cerebral infarction: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 2018. 97(41): p. e12770.

247. Lapergue, B., et al., Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER Randomized Clinical Trial. JAMA, 2017. 318(5): p. 443 - 452.

248. Bourcier, R., et al., Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials. JAMA Neurol, 2019. 76(4): p. 405 - 411.

249. Roman, L.S., et al., Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol, 2018. 17(10): p. 895 - 904.

250. Menon, B.K., et al., Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration. J Neurointerv Surg, 2019.

251. Gory, B., et al., Contact Aspiration Versus Stent Retriever in Patients With Acute Ischemic Stroke With M2 Occlusion in the ASTER Randomized Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization). Stroke, 2018. 49(2): p. 461 - 464.

252. Logan, C., et al., Borderline Alberta Stroke Programme Early CT Score Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion May Find Benefit with Endovascular Thrombectomy. World Neurosurg, 2018. 110: p. e653 - e658.

253. Jiang, S., et al., Endovascular thrombectomy can be beneficial to acute ischemic stroke patients with large infarcts. J Neurosurg, 2018: p. 1 - 8.

254. Albers, G.W., et al., Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med, 2018.

255. Vidale, S., et al., Mechanical Thrombectomy in Strokes with Large-Vessel Occlusion Beyond 6 Hours: A Pooled Analysis of Randomized Trials. Journal of Clinical Neurology, 2018. 14(3).

256. Nogueira, R.G., et al., Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med, 2018. 378(1): p. 11 - 21.

257. Santos, T., et al., NCCT and CTA-based imaging protocol for endovascular treatment selection in late presenting or wake-up strokes. J Neurointerv Surg, 2019. 11(2): p. 200 - 203;

258. Mokin, M., et al., Real-world stent retriever thrombectomy for acute ischemic stroke beyond 6 hours of onset: analysis of the NASA and TRACK registries. J Neurointerv Surg, 2019. 11(4): p. 334 - 337.

259. Sarraj, A., et al., Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient"s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study. JAMA Neurol, 2019.

260. Motyer, R., et al., Endovascular thrombectomy beyond 12 hours of stroke onset: a stroke network"s experience of late intervention. J Neurointerv Surg, 2018. 10(11): p. 1043 - 1046.

261. Goyal, N., et al., Medical Management vs Mechanical Thrombectomy for Mild Strokes. JAMA Neurology, 2019.

262. Xiong, Y.J., et al., Endovascular thrombectomy versus medical treatment for large vessel occlusion stroke with mild symptoms: A meta-analysis. PLoS One, 2018. 13(8): p. e0203066.

263. Schonenberger, S., et al., Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis. JAMA, 2019. 322(13): p. 1283 - 1293.

264. Campbell, B.C.V., et al., Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. The Lancet Neurology, 2018. 17(1): p. 47 - 53.

265. Campbell, B.C., et al., Safety and Efficacy of Solitaire Stent Thrombectomy: Individual Patient Data Meta-Analysis of Randomized Trials. Stroke, 2016. 47(3): p. 798 - 806.

266. Gory, B., et al., Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis. Eur J Neurol, 2018. 25(9): p. 1115 - 1120.

267. Sivan-Hoffmann, R., et al., Stent-Retriever Thrombectomy for Acute Anterior Ischemic Stroke with Tandem Occlusion: A Systematic Review and Meta-Analysis. Eur Radiol, 2017. 27(1): p. 247 - 254.

268. Zhu, F., et al., Impact of Emergent Cervical Carotid Stenting in Tandem Occlusion Strokes Treated by Thrombectomy: A Review of the TITAN Collaboration. Front Neurol, 2019. 10: p. 206.

269. Pires Coelho, A., et al., Overview of evidence on emergency carotid stenting in patients with acute ischemic stroke due to tandem occlusions: a systematic review and meta-analysis. J Cardiovasc Surg (Torino), 2019. 60(6): p. 693 - 702.

270. Anadani, M., et al., Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry. Stroke, 2019. 50(8): p. 2250 - 2252.

271. Bucke, P., et al., Functional Outcome and Safety of Intracranial Thrombectomy After Emergent Extracranial Stenting in Acute Ischemic Stroke Due to Tandem Occlusions. Front Neurol, 2018. 9: p. 940.

272. Sheng, K. and M. Tong, Therapy for acute basilar artery occlusion: a systematic review and meta-analysis. F1000Res, 2019. 8: p. 165.

273. Gory, B., et al., Mechanical thrombectomy in basilar artery occlusion: influence of reperfusion on clinical outcome and impact of the first-line strategy (ADAPT vs stent retriever). J Neurosurg, 2018: p. 1 - 10.

274. Kang, D.H., et al., Endovascular Thrombectomy for Acute Basilar Artery Occlusion: A Multicenter Retrospective Observational Study. J Am Heart Assoc, 2018. 7(14).

275. Eckert, B., et al., Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis, 2002. 14(1): p. 42 - 50.

276. Li, C., et al., Outcome of endovascular treatment for acute basilar artery occlusion in the modern era: a single institution experience. Neuroradiology, 2018. 60(6): p. 651 - 659.

277. Baek, J.H., et al., Endovascular and Clinical Outcomes of Vertebrobasilar Intracranial Atherosclerosis-Related Large Vessel Occlusion. Front Neurol, 2019. 10: p. 215.

278. Sun, X., et al., Endovascular treatment for acute basilar artery occlusion: a single center retrospective observational study. BMC Neurol, 2019. 19(1): p. 315.

279. Maus, V., et al., Intracranial mechanical thrombectomy of large vessel occlusions in the posterior circulation using SAVE. BMCNeurol, 2019. 19(1): p. 197.

280. Домашенко М.А., Танашян М.М. Антиагрегантные препараты в лечении и профилактике цереброваскулярных заболеваний. Русский медицинский журнал, том 16, N 29, с. 1982 - 1986.

281. Diener H.C., Bogousslavsky J. Brass L.M. et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet. 2004; 364: 331 - 337. doi: 10.1016/S0140-6736(04)16721-4;

282. Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348: 1329 - 1339.

283. U.S. Food and Drug Administration. Information for Healthcare Professionals: Update to the Labelling of Clopidogrel Bisulfate (Marketed as Plavix) to Alert Healthcare Professionals About a Drug Interaction With Omeprazole (Marketed as Prilosec and Prilosec OTC). Available at: http://wwwfdagov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190787.htm. Accessed by 24.10.2014.

284. De Schryver EL, Alga A, van Gijn. Dipiridamol: for Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane 2003; CD001820.

285. The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet, 2006, 367: 1665 - 1673.

286. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis, 2008, 25: 457 - 507.

287. ESO (CHARISMA) Bhatt D.L. et al. Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial. J Am Coll Cardiol 2007; 49: 1982-8.

288. Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, et al; SOCRATES Steering Committee and Investigators. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016; 375: 35 - 43. doi: 10.1056/NEJMoa1603060

289. Holster I.L., Valkhoff V.E., Kuipers E.J. et al. New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis. Gastroenterology. 2013; 145 (1): 105-12.

290. Singer DE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 2008 Jun; 133(6 Suppl): 546S-592S. doi: 10.1378/chest.08-0678.

291. Connolly SJ, Connolly SJ, Ezekowitz MD, et al., forthe RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.

292. Granger CB, Alexander JH, McMurray JJ, et al., for the ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-92.

293. Patel MR, Mahaffey KW, Garg J, et al., for the ROCKET-AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-91.

294. Schneeweiss S, Gagne JJ, Patrick AR, Choudkhry NK, Avorn J. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Cardiovasc Qual Outcomes 2012; 5(4): 480-86.

295. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol. 1993; 46: 299 - 303.

296. White RH, McKittrick T, Hutchinson R, et al. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. 1995; 122: 40 - 42.

297. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 2014, 45: 2160 - 2236.

298. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment. Guekht A, Skoog I, Edmundson S, Zakharov V, Korczyn AD. Stroke. 2017 May; 48(5): 1262 - 1270. doi: 10.1161/STROKEAHA.116.014321.40.

299. Суслина З.А. и др. Антиоксидантная терапия при ишемическом инсульте//Журн. неврологии и психиатрии им. Корсакова. - 2000. - Т. 100, N 10. - С. 34 - 38.

300. Zhang L., Yang L. Anti-Inflammatory Effects of Vinpocetine in Atherosclerosis and Ischemic Stroke: A Review of the Literature. Molecules 2015, 20, 335 - 347; doi:10.3390/molecules20010335.

301. Zhang W., Huang Y., Li Y., Tan L., Nao J., Hu H., Zhang J., Li Ch., Kong Y., Song Y. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clin Drug Investig (2016) 36: 697. doi:10.1007/s40261-016-0415-x.

302. Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS, Yakovleva EV. Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis. 2000 Jan-Feb; 10(1): 49 - 60.

303. Chen J, Zhuang Y, Zhang ZF, Wang S, Jin P, He C, Hu PC, Wang ZF, Li ZQ, Xia GM, Li G, Wang Y, Wan Q. Glycine confers neuroprotection through microRNA-301a/PTEN Mol Brain. 2016 May 26; 9(1): 59. doi: 10.1186/s13041-016-0241-3.

304. Gusev EI, Skvortsova VI, Miasoedov NF, Nezavibat"ko VN, Zhuravleva EIu, Vanichkin AV. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study. Zh Nevrol Psikhiatr Im S S Korsakova. 1997; 97(6): 26 - 34.

305. Gusev EI, Skvortsova VI, Chukanova EI. Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency Zh Nevrol Psikhiatr Im S S Korsakova. 2005; 105(2): 35 - 40.

306. The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 23: 3 - 8, 1992.

307. Mohr J.P. et al. Meta-analysis of oral Nimodipine trials in acute ishemic stroke. Cerebrovasc Dis. 1994; 4: 197 - 203.

308. Horn J, de Haan R, Vermeulen M, Limburg M. Very early nimodipine use in stroke (VENUS). Stroke 32: 461 - 465, 2001.

309. Агафьина А., Коваленко А., Румянцева С. и др. Эффективность нейрометаболического протектора Цитофлавина у больных, перенесших ишемический инсульт, в раннем восстановительном периоде (многоцентровое рандомизированное исследование)//Врач. 2006. N 1. с. 60 - 65.

310. Сазонов И.Э., Кудинов А.А., Федотова Е.П. Изучение дозозависимого эффекта цитофлавина в терапии острого периода ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117(2): 64 - 67 https://doi.org/10.17116/jnevro20171172164-67.

311. Muratov FK, Shermukhamedova FK, Batocyrenov BV, Haritonova TV. Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome Zh Nevrol Psikhiatr Im S S Korsakova. 2016; 116(12): 44 - 47. doi: 10.17116/jnevro201611612144-47.

312. Odinak MM, Skvortsova VI, Vozniuk IA, Rumiantseva SA, Stakhovskaia LV, Klocheva EG, Novikova LB, SN, Golokhvastov SIu, Tsygan NV. Efficacy of cytoflavin in patients in the acute ischemic stroke Zh Nevrol Psikhiatr Im S S Korsakova. 2010; 110 (12): 29 - 36.

313. Belova LA, Mashin VV, Abramova VV, Slastyon EY, Belov DV. Efficacy of Korteksin in acute period of hemispheric ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018; 118(7): 30 - 34. doi: 10.17116/jnevro20181187130.

314. Mashin VV, Belova LA, Aizatullin IF, Pavlova VA, Slasten EV, Abramova VV, Belov DV. Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period. Zh Nevrol Psikhiatr Im S S Korsakova. 2019; 119(9): 62 - 67. doi: 10.17116/jnevro201911909162.

315. Wang Z, Shi L, Xu S, Zhang J. Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2017 Apr 19; 11: 1273 - 1282. doi: 10.2147/DDDT.S124273.

316. Zhang D, Dong Y, Li Y, Chen J, Wang J, Hou L. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017; 2017: 4191670. doi: 10.1155/2017/4191670.

317. Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci. 2018 Apr; 39(4): 629 - 640. doi: 10.1007/s10072-017-3214-0. Epub 2017 Dec 16.

318. Сергеев Д.В., Пирадов М.А. Цитиколин в лечении ишемического инсульта - новые доказательства эффективности. Рус. мед. журн. 2012; 31: 1552-54.

319. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology 49: 671 - 678, 1998.

320. Davalos A., J., Castillo J. et al.; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012. V. 380. P. 349 - 357.

321. Overgaard K. The effects of citicoline on acute ischemic stroke: a review. Journal of Stroke and Cerebrovasc Dis. 2014; 23 (7): 1764-9.

322. Одинак М.М., Вознюк И.А., Пирадов М.А. и др. Многоцентровое (пилотное) исследование эффективности глиатилина при остром ишемическом инсульте. Анналы клин. И эксперим. неврологии. 2010; 1: 20 - 28.

323. Barbagallo Sangiorgi G. et al. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann N Y Acad Sci. 1994; 717: 253-69. 49.

324. Скворцова В.И., Стаховская Л.В., Нарциссов Я.Р. и др. Рандомизированное двойное слепое плацебо-контролируемое исследование эффективности и безопасности мексидола в комплексной терапии ишемического инсульта в остром периоде. Журн. невропатол. и психиатр 2006; 18: 47 - 54.

325. Stakhovskaya LV, Shamalov NA, Khasanova DR, et al. The results of a randomized double-blind multicenter, placebo-controlled, parallel-group study of the efficacy and safety of Mexidol during long-term sequential therapy in patients in the acute and early recovery periods of hemispheric ischemic stroke (EPICA). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2017; 117(3): 55 - 65.

326. Vahedi K., Vicaut E., Mateo J. et al. A sequential design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL trial)//Stroke. - 2007. - N 38. - р. 2506 - 2517;

327. Hofmeijer J., Kappelle LJ, Algra A, et al. Hamlet investigators. Surgical decompression for space-occupying cerebral infarction (Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET): a multicentre, open, randomized trial//Lancet Neurology. - 2009. - 8. - p. 326 - 333

328. Крылов В.В., Древаль О.Н., Джинджихадзе Р.С., Лазарев В.А., Дашьян В.Г., Никитин А.С., Петриков С.С. Клинические рекомендации по диагностике и лечению злокачественных форм ишемического инсульта в бассейне средней мозговой артерии. http://ruans.org/Text/Guidelines/ischemic_stroke_severe_form_mca.pdf

329. Xu MY. Poststroke seizure: optimising its management. Stroke Vasc Neurol. 2018; 4(1): 48 - 56. Published 2018 Dec 9. doi:10.1136/svn-2018-000175.

330. Beghi E et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010; 51(4): 671-5.

331. Holtkamp M, Beghi E, Benninger F, et al. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J. 2017; 2(2): 103 - 115. doi:10.1177/2396987317705536.

332. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus-report of the ILAE task force on classification of status epilepticus. Epilepsia 2015; 56 (October (10)) 1515-23.

333. Карлов В.А. Определение и классификация эпилептического статуса (комментарии к докладу Комиссии Международной противоэпилептической лиги). Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2016; 116(9): 32 - 36.

334. Trinka E, J, Zerbs A. Causes of status epilepticus. Epilepsia. 2012; 53 Suppl 4:127-138. doi:10.1111/j.1528-1167.2012.03622.x Trinka E et al, 2012.

335. Guekht A, Bornstein NM. Seizures after stroke. Handb Clin Neurol. 2012; 108: 569-583. doi:10.1016/B978-0-444-52899-5.00016-2.

336. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55(4): 475-482. doi:10.1111/epi.12550

337. Hesdorffer DC, Benn EK, Cascino GD, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009; 50: 1102 - 1108.

338. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000; 57(11): 1617 - 1622. doi:10.1001/archneur.57.11.1617.

339. Tanaka, T., Ihara, M., Post stroke epilepsy, Neurochemistry International (2017), doi: 10.1016/j.neuint.2017.02.002.

340. Guekht A, Mizinova M, Ershov A, et al. In-hospital costs in patients with seizures and epilepsy after stroke. Epilepsia. 2015; 56(8): 1309 - 1313. doi:10.1111/epi.13062,

341. Ferlazzo E, Gasparini S, Beghi E, et al. Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors. Epilepsia. 2016; 57(8): 1205-1214. doi:10.1111/epi.13448al., 2016,

342. Conrad J, Pawlowski M, Dogan M, Kovac S, Ritter MA, Evers S. Seizures after cerebrovascular events: risk factors and clinical features. Seizure. 2013; 22(4): 275 - 282. doi:10.1016/j.seizure.2013.01.014.

343. Xu MY. Stroke and Vascular Neurology 2019; 4:e000175. doi:10.1136/svn-2018-000175

344. Fisher RS, Cross JH, D"Souza C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017; 58(4): 531 - 542. doi:10.1111/epi.13671.

345. Bentes C, Martins H, Peralta AR et al (2017) Epileptic manifestations in stroke patients treated with intravenous alteplase. Eur J Neurol. 2017 Jun; 24(6): 755 - 761. doi: 10.1111/ene.13292. Epub 2017 Apr 18.

346. Sinkin MV, Kaimovsky IL, Komoltsev IG, Trifonov IS, Shtekleyn AA, Tsygankova ME, Guekht AB Electroencephalography in acute stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2020; 120 8. Vyp. 2:10-16. doi: 10.17116/jnevro202012008210.

347. Khomutov VE, , Lebedeva AV, IL, Magomedov RA, Gekht AB. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113 (4 Pt 2): 36 - 40.

348. Flink R, Pedersen B, Guekht AB, et al. Guidelines for the use of EEG methodology in the diagnosis of epilepsy. International League Against Epilepsy: commission report. Commission on European Affairs: Subcommission on European Guidelines. Acta Neurol Scand. 2002; 106(1): 1-7. doi:10.1034/j.1600-0404.2002.01361.

349. Zhao Y, Li X, Zhang K, Tong T, Cui R. The Progress of Epilepsy after Stroke. Curr Neuropharmacol. 2018; 16(1): 71 - 78. doi:10.2174/1570159X15666170613083253.

350. Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015; 32(2): 87-95. doi:10.1097/WNP.0000000000000166.

351. Koubeissi MZ, ed. Seizures in cerebrovascular disorders. New York: Springer Science+Business Media, 2015.

352. Lapalme-Remis S, Cascino GD. Imaging for Adults With Seizures and Epilepsy. Continuum (Minneap Minn). 2016; 22 (5, Neuroimaging): 1451 - 1479. doi:10.1212/CON.0000000000000370.

353. Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019; 60(6): 1054 - 1068. doi: 10.1111/epi.15612.

354. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1): 48 61. doi:10.5698/1535-7597-16.1.48.

355. Trinka E, R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017; 44: 65 - 73. doi:10.1016/j.seizure.2016.11.001.

356. Van Tuijl JH, Van Raak EPM, De Krom MCTFM, Lodder J, Aldenkamp AP. Early treatment after stroke for the prevention of late epileptic seizures: A report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. Seizure. Seizure; 2011; 20: 285-91.

357. Sales F, Chaves J, McMurray R, Loureiro R, Fernandes H, Villanueva V. Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli. Acta Neurol. Scand. 2020. 81. J, Montaner J, L, Molina CA, Rovira R, Codina A, et al. Gabapentin in late-onset poststroke seizures. Neurology. 2002; 59: 1991-3.

358. Brigo F, Nardone R, Tezzon F, Trinka E. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis. Epilepsy Behav. 2015 Aug; 49: 325-36.

359. Brigo F, Lattanzi S, Zelano J, Bragazzi NL, Belcastro V, Nardone R, Trinka E. Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis. Seizure. 2018 Oct; 61: 57 - 62.

360. Werhahn KJ, Trinka E, Dobesberger J, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015; 56(3): 450 - 459. doi: 10.1111/epi.12926.

361. Zelano J. Poststroke epilepsy: update and future directions. Ther Adv Neurol Disord. 2016 Sep; 9(5): 424-35.

362. Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013; 54: 551-63.

363. Lenzi GL, Altieri M, Maestrini I. Post-stroke depression. Rev Neurol (Paris). 2008 Oct; 164(10): 837-40. doi: 10.1016/j.neurol.2008.07.010. Epub 2008 Sep 3. PMID: 18771785.

364. Lerdal A, Kottorp A, Gay CL, Grov EK, Lee KA. Rasch analysis of the Beck Depression Inventory-II in stroke survivors: a cross-sectional study. J Affect Disord. 2014 Apr; 158: 48 - 52. doi: 10.1016/j.jad.2014.01.013. Epub 2014 Feb 5. PMID: 24655764.

365. Kutlubaev MA, Hackett ML. Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke. 2014 Dec; 9(8): 1026-36. doi: 10.1111/ijs.12356

366. Lees R, Stott DJ, Quinn TJ, Broomfield NM. Feasibility and diagnostic accuracy of early mood screening to diagnose persisting clinical depression/anxiety disorder after stroke. Cerebrovasc Dis. 2014; 37(5): 323-9. doi: 10.1159/000360755. Epub 2014 Jun 4. PMID: 24903316.

367. Mitchell A.J. et al. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder//General Hospital Psychiatry. - 2017. - Т. 47. - С. 48 - 60.

368. Qin B, Chen H, Gao W, et al. Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis. Braz J Med Biol Res. 2018; 51(7): e7218. doi: 10.1590/1414-431x20187218;

369. Legg LA, Tilney R, Hsieh CF, Wu S, E, Rudberg AS, Kutlubaev MA, Dennis M, Soleimani B, Barugh A, Hackett ML, Hankey GJ, Mead GE. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2019 Nov 26; 2019(11): CD009286. doi: 10.1002/14651858.CD009286.pub3. PMID: 31769878; PMCID: PMC6953348

370. Zhou S, Liu S, Liu X, Zhuang W. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis. Medicine (Baltimore). 2020 Feb; 99(6): e19062. doi: 10.1097/MD.0000000000019062. PMID: 32028426; PMCID: PMC7015581.

371. Farooq, D.S., Singh, D.S.P., Burke, D.D., Naeem, D.F., & Ayub, D.M. (2020). Pharmacological interventions for prevention of depression in high risk conditions: systematic review and meta-analysis. Journal of Affective Disorders. doi: 10.1016/j.jad.2020.03.024.

372. Gu, J., Huang, H., Chen, K., Huang, G., Huang, Y., & Xu, H. (2019). Are they necessary? Preventive therapies for post-stroke depression: a meta-analysis of RCTs. Psychiatry Research, 112670. doi: 10.1016/j.psychres.2019.112670; 2019.

373. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 393 (10168), 265 - 274.

374. Bai ZF, Wang LY. Efficacy of sertraline for post-stroke depression: A systematic review protocol of randomized controlled trial. Medicine (Baltimore). 2019 Apr; 98(16): e15299. doi: 10.1097/MD.0000000000015299. PMID: 31008979; PMCID: PMC6494403.

375. Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, Zhao C. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ Open. 2017 Aug 3; 7(8): e016499. doi: 10.1136/bmjopen-2017-016499. PMID: 28775189; PMCID: PMC5629745.

376. Starkstein SE, Hayhow BD. Treatment of Post-Stroke Depression. Curr Treat Options Neurol. 2019 Jun 25; 21(7): 31. doi: 10.1007/s11940-019-0570-5. PMID: 31236751.

377. Lee EJ, Oh MS, Kim JS, Chang DI, Park JH, Cha JK, Heo JH, Sohn SI, Kim DE, Kim HY, Kim J, Seo WK, Lee J, Park SW, Kim YJ, Lee BC; EMOTION investigators. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use. J Neurol Neurosurg Psychiatry. 2018 Mar; 89(3): 271 - 276. doi: 10.1136/jnnp-2017-316882. Epub 2017 Oct 13. PMID: 29030421.

378. Cui M, Huang CY, Wang F. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11): 2905-2918. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.027. Epub 2018 Sep 7. PMID: 30201459.

379. Deng L, Sun X, Qiu S, Xiong Y, Li Y, Wang L, Wei Q, Wang D, Liu M. Interventions for management of post-stroke depression: A Bayesian network meta-analysis of 23 randomized controlled trials. Sci Rep. 2017 Nov 28; 7(1): 16466. doi: 10.1038/s41598-017-16663-0. PMID: 29184194; PMCID: PMC5705605.

380. Meent, H.V. de, Geurts, A.C.H., & Limbeek, J.V. (2003). Pharmacologic Treatment of Poststroke Depression: A Systematic Review of the Literature. Topics in Stroke Rehabilitation, 10(1), 79 - 92. doi: 10.1310/b51g-29mp-25hq-arnh

381. Wang SB, Wang YY, Zhang QE, Wu SL, Ng CH, Ungvari GS, Chen L, Wang CX, Jia FJ, Xiang YT. Cognitive behavioral therapy for post-stroke depression: A meta-analysis. J Affect Disord. 2018 Aug 1; 235: 589 - 596. doi: 10.1016/j.jad.2018.04.011. Epub 2018 Apr 5. PMID: 29704854.

382. Sarfo FS, Ulasavets U, Opare-Sem OK, Ovbiagele B. Tele-Rehabilitation after Stroke: An Updated Systematic Review of the Literature. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9): 2306-2318. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.013. Epub 2018 Jun 4. PMID: 29880211; PMCID: PMC6087671.

383. Fure B. Depresjon, angst og andre emosjonelle symptomer ved hjerneslag [Depression, anxiety and other emotional symptoms after cerebral stroke]. Tidsskr Nor Laegeforen. 2007 May 17; 127(10): 1387-9. Norwegian. PMID: 17519996.

384. Murray V, B. Emotionella reaktioner vanliga restsymtom efter stroke [Emotional reactions common sequelae of stroke]. Lakartidningen. 2004 Jun 10; 101(24): 2108-10, 2112-3, 2115. Swedish. PMID: 15282986.

385. Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, Knapp P. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2011 Dec 7; (12): CD008860. doi: 10.1002/14651858.CD008860.pub2. Update in: Cochrane Database Syst Rev. 2017 May 23; 5: CD008860. PMID: 22161439.

386. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012 Nov 14; 11(11): CD009286. doi: 10.1002/14651858.CD009286.pub2. Update in: Cochrane Database Syst Rev. 2019 Nov 26; 2019(11): PMID: 23152272; PMCID: PMC6465036.

387. Kim JS (2017). Management of post-stroke mood and emotional disturbances. Expert Review of Neurotherapeutics, 17(12), 1179 - 1188. doi: 10.1080/14737175.2017.1395281.

388. Wright F, Wu S, Chun HY, Mead G. Factors Associated with Poststroke Anxiety: A Systematic Review and Meta-Analysis. Stroke Res Treat. 2017; 2017: 2124743. doi: 10.1155/2017/2124743. Epub 2017 Feb 22. PMID: 28321357; PMCID: PMC5340955.

389. Li W, Xiao WM, Chen YK, Qu JF, Liu YL, Fang XW, Weng HY, Luo GP. Anxiety in Patients With Acute Ischemic Stroke: Risk Factors and Effects on Functional Status. Front Psychiatry. 2019 Apr 17; 10: 257. doi: 10.3389/fpsyt.2019.00257. PMID: 31057444; PMCID: PMC6478797.

390. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012 Nov 14; 11(11): CD009286. doi: 10.1002/14651858.CD009286.pub2. Update in: Cochrane Database Syst Rev. 2019 Nov 26; 2019(11): PMID: 23152272; PMCID: PMC6465036.

391. Mikami K, Jorge RE, Moser DJ, et al. Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy. J Neuropsychiatry Clin Neurosci 2014; 26: 323-8.

392. Knapp P, Campbell Burton CA, Holmes J, Murray J, Gillespie D, Lightbody CE, Watkins CL, Chun HY, Lewis SR. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2017 May 23; 5(5): CD008860. doi: 10.1002/14651858.CD008860.pub3. PMID: 28535332; PMCID: PMC6481423.

393. Zhang YX, Zhang HL, Wang H. Effects of buspirone hydrochloride on post-stroke affective disorder and neural function. Chinese Journal of Clinical Rehabilitation 2005; 9

394. Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011; 152(5): 1018 - 1023. doi: 10.1016/j.pain.2010.12.023.

395. AA, Stibrant Sunnerhagen K, Golyk V, et al. Evidence-based position paper on Physical and Rehabilitation Medicine professional practice for persons with stroke. The European PRM position (UEMS PRM Section). Eur J Phys Rehabil Med. 2019; 54(6): 957 - 970. doi: 10.23736/s1973-9087.18.05501-6.

396. Janne Veerbeek et al. Clinical Practice Guideline for Physical Therapy in Patients with Stroke. Royal Dutch Society for Physical Therapy.; 2014, P74.

397. Vasudevan JM, Browne BJ. Hemiplegic shoulder pain: an approach to diagnosis and management. PhysMedRehabilClinNAm2014; 25: 411-37.

398. Приказ Министерства здравоохранения РФ от 31 июля 2020 г. N 778н "О Порядке организации медицинской реабилитации взрослых" Зарегистрировано в Минюсте РФ 25 сентября 2020 г. Регистрационный N 60039

399. Winstein, C.J., J. Stein, R. Arena, B. Bates, L.R. Cherney, S.C. Cramer, F. Deruyter, J.J. Eng, B. Fisher, R.L. Harvey, C.E. Lang, M. MacKay-Lyons, K.J. Ottenbacher, S. Pugh, M.J. Reeves, L.G. Richards, W. Stiers, R.D. Zorowitz, Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2016. 47(6): p. e98 - e169

400. Saunders DH, Sanderson M, Hayes S, Johnson L, Kramer S, Carter DD, Jarvis H, Brazzelli M, Mead GE. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 2020 Mar 20; 3(3): CD003316. doi: 10.1002/14651858.CD003316.pub7. PMID: 32196635; PMCID: PMC7083515.

401. MD, Molina-Rueda F, A, - Tejada M, Alguacil-Diego IM, Miangolarra-Page JC. Scales to assess gross motor function in stroke patients: a systematic review. Arch Phys Med Rehabil 2014; 95: 1174-83.

402. Outcome Measures in Stroke Rehabilitation. Evidence-Based Review of Stroke Rehabilitation; 2015, London, Ontario, Canada. Available from http://www.ebrsr.com/evidence-review.

403. Hebert D, Lindsay MP, McIntyre A, Kirton A, Rumney PG, Bagg S, et al. Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015. Int J Stroke 2016; 11: 459-84.

404. Coleman ER, Moudgal R, Lang K, Hyacinth HI, Awosika OO, Kissela BM, et al. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep 2017; 19: 59.

405. Иванова Г.Е., Кривобородов Г.Г., Салюков Р.В., Бушков Ф.А., Ефремов Н.С., Кадыров З.А. Коррекция функциональных нарушений опорожнения мочевого пузыря при неврологических заболеваниях методом периодической катетеризации. Клинические рекомендации. Москва, 2016, 40 с.

406. National Institute of Health for Health and Care Excellence - NICE. Stroke rehabilitation in adults. Clinical guideline (CG162), June 2013. Available from https://www.nice.org.uk/guidance/cg162].

407. Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. Occupational therapy for adults with problems in activities of daily living after stroke. Cochrane Database Syst Rev 2017; 7: CD003585.

408. Zhang C, Li-Tsang CW, Au RK. Robotic approaches for the rehabilitation of upper limb recovery after stroke: a systematic review and meta-analysis. Int J Rehabil Res 2017; 40: 19 - 28.

409. Veerbeek JM, Langbroek-Amersfoort AC, van Wegen EE, Meskers CG, Kwakkel G. Effects of Robot-Assisted Therapy for the Upper Limb After Stroke. Neurorehabil Neural Repair 2017; 31: 107 - 121.

410. Nadler M, Pauls M. Shoulde orthoses for the prevention and reduction of hemiplegic shoulder pain and subluxation: systematic review. Clin Rehabil 2017; 31: 444 - 453. 2016; 97: 1366-80.

411. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, et al. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2532-53.

412. Brady MC, Kelly H, Godwin J, Enderby P, Campbell P. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2016; 6: CD000425.

413. Mitchell C, Bowen A, Tyson S, Butterfint Z, Conroy P. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database Syst Rev 2017; 1: CD002088.

414. Beristain X, Golombievski E. Pharmacotherapy to Enhance Cognitive and MotorRecovery Following Stroke. Drugs Aging 2015; 32: 765-72.

415. Russo MJ, Prodan V, Meda NN, Carcavallo L, Muracioli A, Sabe L, et al. High-technology augmentative communication for adults with post-stroke aphasia: a systematic review. Expert Rev Med Devices 2017; 14: 355 - 370.

416. Eskes GA, KL, Herrmann N, Lindsay P, Bayley M, Bouvier L, et al. Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015. Int J Stroke 2015; 10: 1130-40.

417. Bowen A, Hazelton C, Pollock A, Lincoln NB. Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev. 2013; 7: CD003586. doi: 10.1002/14651858.CD003586.pub3.

418. Robinson RG, Jorge RE. Post-Stroke Depression: A Review. Am J Psychiatry 2016; 173: 221-31.

419. Eng JJ, Reime B. Exercise for depressive symptoms in stroke patients: a systematic review and meta-analysis. Clin Rehabil 2014; 28: 731 - 739.

420. Thomas LH, Cross S, Barrett J, French B, Leathley M, Sutton CJ, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008; 1: CD004462.

421. Panfili Z, Metcalf M, Griebling TL. Contemporary Evaluation and Treatment of Poststroke Lower Urinary Tract Dysfunction. Urol Clin North Am 2017; 44: 403 - 414.

422. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists" Collaboration. BMJ. 1997 Apr 19; 314(7088): 1151-9.

423. Белкин А.А. Синдром последствий интенсивной терапии (ПИТ-синдром). Вопросы интенсивной терапии имени А.И. Салтанова. 2018; 2: 12 - 23.

424. Langhorne P, Collier JM, Bate PJ, Thuy MN, Bernhardt J. Very early versus delayed mobilisation after stroke. Cochrane Database Syst Rev. 2018 Oct 16; 10(10): CD006187. doi: 10.1002/14651858.CD006187.pub3. PMID: 30321906; PMCID: PMC6517132.

425. Daniels SK, Anderson JA, Willson PC. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke. 2012 Mar; 43(3): 892-7. doi: 10.1161/STROKEAHA.111.640946. Epub 2012 Feb 2. PMID: 22308250].

426. Burgos R, I, Cereda E, et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2017; 37: 354 - 396. doi: 10.1016/j.clnu.2017.09.003.

427. , Tervaniemi M, Laitinen S, Forsblom A, Soinila S, Mikkonen M, Autti T, Silvennoinen HM, J, Laine M, Peretz I, Hietanen M. Music listening enhances cognitive recovery and mood after middle cerebral artery stroke. Brain. 2008 Mar; 131 (Pt 3): 866-76. doi: 10.1093/brain/awn013. PMID: 18287122.

428. Koog YH, Jin SS, Yoon K, Min BI. Interventions for hemiplegic shoulder pain: systematic review of randomised controlled trials. Disabil Rehabil. 2010; 32(4): 282-91. doi: 10.3109/09638280903127685. PMID: 20055567.

429. Wattchow KA, McDonnell MN, Hillier SL. Rehabilitation Interventions for Upper Limb Function in the First Four Weeks Following Stroke: A Systematic Review and Meta-Analysis of the Evidence. Arch Phys Med Rehabil 2018; 99: 367 - 382.

430. Vaughan-Graham J, Cott C, Wright FV. The Bobath (NDT) concept in adult neurological rehabilitation: what is the state of the knowledge? A scoping review. Part II: intervention studies perspectives. Disabil Rehabil 2015; 37: 1909-28.

431. Howlett OA, Lannin NA, Ada L, McKinstry C. Functional electrical stimulation improves activity after stroke: a systematic review with meta-analysis. Arch Phys Med Rehabil 2015; 96: 934-43.

432. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Аронов Д.М., Белкин А.А., Беляев А.Ф., Бодрова Р.А., Бубнова М.Г., Буйлова Т.В., Мальцева М.Н., Мишина И.Е., Нестерин К.В., Никифоров В.В., Прокопенко С.В., Сарана А.М.О., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Цыкунов М.Б. и др. Пилотный проект "Развитие системы медицинской реабилитации в Российской Федерации": Предварительные результаты реализации на первом и втором этапах медицинской реабилитации. Вестник восстановительной медицины. 2017. N 2 (78). С. 10 - 15.

433. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Белкин А.А., Бодрова Р.А., Лебедев П.В., Мальцева М.Н., Прокопенко С.В., Просвирнина М.С., Сарана А.М., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Шамалов Н.А. Оценка эффективности работы мультидисциплинарной бригады как новой модели оказания реабилитационной помощи пациентам с церебральным инсультом. Вестник РНИМУ, выпуск 6, 2019, С. 5 - 15.

434. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2016; 47: e98 - e169.

435. Tchero H, Tabue Teguo M, Lannuzel A. Telerehabilitation for Stroke Survivors: Systematic Review and Meta-Analysis. Rusch E.J Med Internet Res. 2018 Oct 26; 20(10): e10867. doi: 10.2196/10867.

436. Laver KE, Schoene D, Crotty M, George S, Lannin NA, Sherrington C. Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: CD010255.

437. Chen J, Jin W, Zhang XX, Xu W, Liu XN, Ren CC. Telerehabilitation approaches for stroke patients: Systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis 2015; 24: 2660-8.

438. Tyson SF, Rogerson L. Assistive walking devices in nonambulant patients undergoing rehabilitation after stroke: the effects on functional mobility, walking impairments, and patients' opinion. Arch Phys Med Rehabil. 2009; 90: 475 - 479. doi: 10.1016/j.apmr.2008.09.563.

439. Laufer Y. Effects of one-point and four-point canes on balance and weight distribution in patients with hemiparesis. Clin Rehabil. 2002; 16: 141 - 148.

440. White Book on Physical and rehabilitation Medicine (PRM) in Europe. Chapter 3. A primary medical specialty: the Fundamentals of PRM. Eur J Phys Rehabil Med 2018; 4: 177-85.

441. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Аронов Д.М., Белкин А.А., Беляев А.Ф., Бодрова Р.А., Бубнова М.Г., Буйлова Т.В., Мальцева М.Н., Мишина И.Е., Нестерин К.В., Никифоров В.В., Прокопенко С.В., Сарана А.М., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Цыкунов М.Б. и др. Применение международной классификации функционирования в процессе медицинской реабилитации. Вестник восстановительной медицины. 2018. N 6 (88). С. 2 - 77.

442. J Rehabil Med 2011; 43: 661-72; Velstra IM, Ballert CS, Cieza A. A systematic literature review of outcome measures for upper extremity function using the international classification of functioning, disability, and health as reference. PM R 2011; 3: 846-60.

443. Variations in follow-up services after inpatient stroke rehabilitation: a multicentre study. J Rehabil Med 2009; 41: 646-53; Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet 2011; 377(9778): 1693-702

444. Systematic review of outcome measures of walking training using electromechanical and robotic devices in patients with stroke. J Rehabil Med 2013; 45: 987-96; Feigin VL, Norrving B, Mensah GA. Global burden of stroke. CircRes 2017; 120: 439 - 448.

445. Суворов А.Ю., Иванова Г.Е., Стаховская Л.В. Позиционирование пациента с очаговыми поражениями головного мозга. Вестник восстановительной медицины. 2016. N 2 (72). С. 55 - 58.

446. Rosales, R.L., F. Efendy, E.S. Teleg, M.M. Delos Santos, M.C. Rosales, M. Ostrea, M.J. Tanglao, A.R. Ng, Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. Journal of the neurological sciences, 2016. 371: p. 6 - 14.

447. Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; on behalf of the American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010; 41: 2402 - 2448. doi: 10.1161/STR.0b013e3181e7512b.

448. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990 - 2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913): 245-54. The Burden of Stroke in Europe. Report. King's College London for the Stroke Alliance for Europe (SAFE). Available from: http://strokeeurope.eu.

449. Gadidi V, Katz-Leurer M, Carmeli E, Bornstein NM. Long-term outcome poststroke: predictors of activity limitation and participation restriction. Arch Phys Med Rehabil 2011; 92: 1802-8.

450. Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Med J Malaysia. 2007 Oct; 62(4): 319-22. PMID: 18551937.

451. Poststroke Spasticity Management Gerard E. Francisco and John R. McGuire Originally published13 Sep 2012 https://doi.org/10.1161/STROKEAHA.111.639831Stroke. 2012; 43: 3132 - 3136.

452. Khan F., Amatya B., Bensmai lD., Yelnik A. Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews Ann Phys Rehabil Med 2019 Jul; 62(4): 265 - 273. doi: 10.1016/j.rehab.2017.10.001.Epub 2017 Oct 16.

453. Medici M, Pebet M, Ciblis D. A double-blind, long-term study of tizanidine ("Sirdalud") in spasticity due to cerebrovascular lesions. Curr Med Res Opin. 1989; 11: 398 - 407.

454. Боголепова А.Н., Васенина Е.Е., Захаров В.В., Катунина Е.А., Левин О.С., Литвиненко И.В., Преображенская И.С., Фукалов Ю.А., Шкловский В.М., Цыган Н.В., Яхно Н.Н. Реабилитации высших психических функций у больных с очаговым поражением головного мозга. Клинические рекомендации, Москва, 2018, 88 с.

455. Stamenova P, Koytchev R, Kuhn K, Hansen C, Horvath F, Ramm S, Pongratz D. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Eur J Neurol. 2005 Jun; 12(6): 453-61. doi: 10.1111/j.1468-1331.2005.01006.x. PMID: 15885050.

456. Creamer M, Cloud G, Kossmehl P, Yochelson M, Francisco GE, Ward AB, Wissel J, Zampolini M, Abouihia A, Calabrese A, Saltuari L. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity. Stroke. 2018 Sep; 49(9): 2129 - 2137. doi: 10.1161/STROKEAHA.118.022255. PMID: 30354975; PMCID: PMC6116794.

457. Teasell R, Foley N, Martino R, Bhogal S, Speechley M. Dysphagia and aspiration post stroke. Evidence-Based Review of Stroke Rehabilitation. 12th ed. 2008. EBRSR Web site. Available at: http: //www.ebrsr.com/reviews_details.php? Dysphagia-and-Aspiration-Post-Stroke-29. Accessed July 25, 2009.

458. Viana R, Pereira S, Mehta S, Miller T, Teasell R. Evidence for therapeutic interventions for hemiplegic shoulder pain during the chronic stage of stroke: a review. Top Stroke Rehabil 2012; 19: 514-22.

459. Corbetta D, Sirtori V, Castellini G, Moja L, Gatti R. Constraint-induced movement therapy for upper extremities in people with stroke. Cochrane Database Syst Rev. 2015; 2015(10): CD004433. Published 2015 Oct 8. doi: 10.1002/14651858.CD004433.pub3

460. Инсульт у взрослых: центральный парез верхней конечности. Клинические рекомендации. Москва, 2017. 105 с.

461. Barclay RE, Stevenson TJ, Poluha W, Semenko B, Schubert J. Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke. Cochrane Database Syst Rev. 2020 May 25; 5(5): CD005950. doi: 10.1002/14651858.CD005950.pub5. PMID: 32449959; PMCID: PMC7387111.

462. Mehrholz J, Pohl M, Platz T, Kugler J, Elsner B. Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev. 2018 Sep 3; 9(9): CD006876. doi: 10.1002/14651858.CD006876.pub5.

463. Park KD, Kim TH, Lee SH. The Gugging Swallowing Screen in dysphagia screening for patients with stroke: A systematic review. Int J Nurs Stud. 2020 Jul; 107: 103588. doi: 10.1016/j.ijnurstu.2020.103588. Epub 2020 Apr 18. PMID: 32408200.

464. Логопедическая диагностика и реабилитация пациентов с повреждениями головного мозга в остром периоде. Клинические рекомендации. Ахутина Т.В., Микадзе Ю.В., Иванова М.В., Ларина О.Д., Норвилс С.Н., Царева И.В. Москва, 2014. 46 с.

465. Скворцов Д.В., Прокопенко С.В., Аброськина М.В., Кайгородцева С.А., Ястребцева И.П., Климов Л.В. к.м.н., Левин О.С., Скрипкина Н.А., Буйлова Т.В. Диагностика и реабилитация нарушений функций ходьбы и равновесия при синдроме центрального гемипареза. Клинические рекомендации. Москва, 2016. 30 с.

466. Lee J, Stone AJ. Combined Aerobic and Resistance Training for Cardiorespiratory Fitness, Muscle Strength, and Walking Capacity after Stroke: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2020 Jan; 29(1): 104498. doi: 10.1016/j.jstrokecerebrovasdis. 2019. 104498. Epub 2019 Nov 13. PMID: 31732460.

467. Watson JC, Sandroni P. Central Neuropathic Pain Syndromes. Mayo Clin Proc 2016; 91: 372-85.

468. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists" Collaboration, Meta-Analysis, BMJ, 1997 Apr 19; 314(7088): 1151-9.

469. Berthold Kepplinger, Repetitive Transcranial Magnetic Stimulation and Stroke Rehabilitation, J Neurodegeneration and NeuroRehabilitation. 2018. Doi: http://doi.org//10.31579/2578-8868/1.10023.

470. Mehrholz J, Pohl M, Kugler J, Elsner B: The improvement of walking ability following stroke - a systematic review and network meta-analysis of randomized controlled trials. Dtsch Arztebl Int 2018; 115: 639-45. DOI: 10.3238/arztebl.2018.0639.

471. Mehrholz J, Thomas S, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev. 2017 Aug 17; 8(8): CD002840. doi: 10.1002/14651858.CD002840.pub4. PMID: 28815562; PMCID: PMC6483714.

472. Prenton S, Hollands KL, Kenney LP. Functional electrical stimulation versus ankle foot orthoses for foot-drop: A meta-analysis of orthotic effects. J Rehabil Med 2016; 48: 646 - 656.

473. de Rooij IJ, van de Port IG, Meijer JG. Effect of Virtual Reality Training on Balance and Gait Ability in Patients With Stroke: Systematic Review and Meta-Analysis. Phys Ther. 2016 Dec; 96(12): 1905 - 1918. doi: 10.2522/ptj.20160054. Epub 2016 May 12. PMID: 27174255.

474. Laver KE, Lange B, George S, Deutsch JE, Saposnik G, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev 2017; 11: CD008349.

475. Nadler M, Pauls M. Shoulder orthoses for the prevention and reduction of hemiplegic shoulder pain and subluxation: systematic review. Clin Rehabil 2017; 31: 444 - 453.

476. Prenton S, Hollands KL, Kenney LP. Functional electrical stimulation versus ankle foot orthoses for foot-drop: A meta-analysis of orthotic effects. J Rehabil Med 2016; 48: 646 - 656.

477. Mehta S, Pereira S, Viana R, Mays R, McIntyre A, Janzen S, et al. Resistance training for gait speed and total distance walked during the chronic stage of stroke: a meta-analysis. Top Stroke Rehabil 2012; 19: 471-8.

478. States RA, Pappas E, Salem Y. Overground physical therapy gait training for chronic stroke patients with mobility deficits. Cochrane Database Syst Rev 2009; 3: CD006075.

479. Campbell GB, Matthews JT. An integrative review of factors associated with falls during post-stroke rehabilitation. J Nurs Scholarsh 2010; 42: 395 - 404.

480. Hatem, S.M., G. Saussez, M. Della Faille, V. Prist, X. Zhang, D. Dispa, Y. Bleyenheuft, Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Frontiers in human neuroscience, 2016. 10: p. 442.

481. Sorinola IO, Powis I, White CM. Does additional exercise improve trunk function recovery in stroke patients? A meta-analysis. NeuroRehabilitation 2014; 35: 205-13.

482. Keller I, Lefin-Rank G. Improvement of visual search after audiovisual exploration training in hemianopic patients. Neurorehabil Neural Repair. 2010 Sep; 24(7): 666-73. doi: 10.1177/1545968310372774. PMID: 20810740.

483. van Heugten C, GW, Wade D. Evidence-based cognitive rehabilitation after acquired brain injury: a systematic review of content of treatment. Neuropsychol Rehabil 2012; 22: 653-73.

484. Poulin V, Korner-Bitensky N, Dawson DR, Bherer L. Efficacy of executive function interventions after stroke: a systematic review. Top Stroke Rehabil 2012; 19: 158-71.

485. Wondergem R., Pisters M.F., Wouters E.J., Olthof N., de Bie R.A., Visser-Meily J.M.A., Veenhof C. The Course of Activities in Daily Living: Who Is at Risk for Decline after First Ever Stroke? Cerebrovasc Dis. 2017; 43(1-2): 1 - 8. doi: 10.1159/000451034. Epub 2016 Oct 18.

486. Rebchuk AD, O"Neill ZR, Szefer EK, Hill MD, Field TS. Health Utility Weighting of the Modified Rankin Scale: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 Apr 1; 3(4): e203767. doi: 10.1001/jamanetworkopen.2020.3767. PMID: 32347948; PMCID: PMC7191324.

487. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke1991; 22: 983 - 988.

488. CAPRIE Steering Committee. Lancet, 1996; 348: 1329 - 1339.

489. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Ассоциация флебологов России, Всероссийское общество хирургов, 2013.

490. Prevention and treatment of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). Under the auspices of the Cardiovascular Disease Educational and Research Trust, European Venous Forum, North American Thrombosis Forum, International Union of Angiology and Union Internationale du Phlebologie - 2013. P. 111 - 260.

491. Ekundayo OJ, Saver JL, Fonarow GC, Schwamm LH, Xian Y, Zhao X, Hernandez AF, Peterson ED, Cheng EM. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With The Guidelines-Stroke.Circ Cardiovasc Qual Outcomes. 2013; 6: 262 - 269.

492. Mochari-Greenberger H, Xian Y, Hellkamp AS, Schulte PJ, Bhatt DL, Fonarow GC, Saver JL, Reeves MJ, Schwamm LH, Smith EE. Racial/ethnic and sex differences in emergency medical services transport among hospitalized US Stroke patients: analysis of the national Get With The Guidelines-Stroke Registry. J Am Heart Assoc. 2015; 4: e002099.

493. Boden-Albala B, Stillman J, Roberts ET, Quarles LW, Glymour MM, Chong J, Moats H, Torrico V, Parides MC. Comparison of acute stroke preparedness strategies to decrease emergency department arrival time in a multiethnic cohort: the Stroke Warning Information and Faster Treatment Study. Stroke. 2015; 46: 1806 - 1812. doi: 10.1161/STROKEAHA.114.008502.

495. Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003; 34: 71 - 76.

496. Studnek JR, Asimos A, Dodds J, Swanson D. Assessing the validity of the Cincinnati Prehospital Stroke Scale and the Medic Prehospital Assessment For Code Stroke in an urban emergency medical services agency. Prehosp Emerg Care 2013; 17: 348 - 353.

497. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000; 31: 71 - 76.

498. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. Paramedic identification of stroke: community validation of the Melbourne Ambulance Stroke Screen. Cerebrovasc Dis 2005; 20: 28 - 33.

499. Chenkin J, Gladstone DJ, Verbeek PR, et al. Predictive value of the Ontario prehospital stroke screening tool for the identification of patients with acute stroke. Prehosp Emerg Care 2009; 13: 153 - 159.

500. Fothergill RT, Williams J, Edwards MJ, Russell IT, Gompertz P. Does use of the recognition of stroke in the emergency room stroke assessment tool enhance stroke recognition by ambulance clinicians? Stroke 2013; 44: 3007 - 3012.

501. Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Saver JL. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care 2004; 8: 46 - 50.

502. Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, Olson DM, Shah BR, Hernandez AF, Schwamm LH, Fonarow GC. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2012; 5: 514 - 522.

503. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, Starke RD, Todd HW, Viste KM, Girgus M, Shephard T, Emr M, Shwayder P, Walker MD. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA. 2000; 283: 3102 - 3109.

504. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, O'Connor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005; 36: 1597 - 1616.

505. Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013; 309: 2480 - 2488.

506. Higashida R, Alberts MJ, Alexander DN, Crocco TJ, Demaerschalk BM, Derdeyn CP, Goldstein LB, Jauch EC, Mayer SA, Meltzer NM, Peterson ED, Rosenwasser RH, Saver JL, Schwamm L, Summers D, Wechsler L, Wood JP; American Heart Association Advocacy Coordinating Committee. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke. 2013 Oct; 44(10): 2961-84.

507. Gerschenfeld G, Muresan I, Blanc R, et al. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke. JAMA Neurol. 2017; 74(5): 549 - 556.

508. Holodinsky JK, Williamson TS, Demchuk AM, et al. Modeling Stroke Patient Transport for All Patients with Suspected Large-Vessel Occlusion. JAMA Neurol. 2018; 75(12): 1477 - 1486.

509. Justin L. Benoit, Pooja Khatri, Opeolu M. Adeoye, Joseph P. Broderick, Jason T. McMullan, Jan F. Scheitz, Achala S. Vagal & Mark H. Eckman (2018) Prehospital Triage of Acute Ischemic Stroke Patients to an Intravenous tPA-Ready versus Endovascular-Ready Hospital: A Decision Analysis, Prehospital Emergency Care, 22: 6, 722 - 733.

510. Nazliel B, Starkman S, Liebeskind DS, et al. A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke 2008; 39: 2264 - 2267.

511. Brandler ES, Sharma M, Sinert RH, Levine SR. Prehospital stroke scales in urban environments: a systematic review. Neurology 2014; 82: 2241 - 2249.

512. Приказ Министерства здравоохранения РФ от 15 ноября 2012 г. N 928н "Об утверждении Порядка оказания медицинской помощи больным с острыми нарушениями мозгового кровообращения".

513. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, DawsonHughes B. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr. 2004 Sep; 80(3): 752-8.

514. Holmes M., Rathbone J., Littlewood C., Rawdin A., Stevenson M., Stevens J., Archer R., Evans P., Wang J. Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. Health Technol Assess. 2014 Mar; 18(16): 1 - 176. doi: 10.3310/hta18160.

515. Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014: CD000029. doi: 10.1002/14651858.CD000029.pub3516.

516 Paciaroni M, Ince B, Hu B, et al. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis. Cardiovasc Ther. 2019; 2019: 1607181. doi: 10.1155/2019/1607181.

517. Bath PM, Woodhouse LJ, Appleton JP, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018; 391(10123): 850 - 859. doi: 10.1016/S0140-6736(17) 32849-0.

518. Kim JY, Kim S-H, Myong J-P, et al. Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis. J Am Coll Cardiol. 2019; 73(10): 1123 - 1131. doi: 10.1016/j.jacc.2018.12.047.

519. Rajwani KM, Crocker M, Moynihan B. Decompressive craniectomy for the treatment of malignant middle cerebral artery infarction. Br J Neurosurg. 2017; 31(4): 401 - 409. doi: 10.1080/02688697.2017.1329518.

520. Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018; 379: 215 - 225. doi: 10.1056/NEJMoa1800410.

521. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369: 11 - 19. doi: 10.1056/NEJMoa1215340.

522. Cort s-Vicente E, Guisado-Alonso D, Delgado-Mederos R, Camps-Renom P, L, A, J. Frequency, Risk Factors, and Prognosis of Dehydration in Acute Stroke. Front Neurol. 2019 Mar 29; 10: 305. doi: 10.3389/fneur.2019.00305. Erratum in: Front Neurol. 2020 Jul 17; 11: 717. PMID: 30984104; PMCID: PMC6450136.

523. Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018 Oct; 121(4): 706 - 721. doi: 10.1016/j.bja.2018.04.036. Epub 2018 Jun 20. PMID: 30236233.

524. Bednarczyk JM, Fridfinnson JA, Kumar A, et al. Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis. Crit Care Med. 2017; 45(9): 1538 - 1545. doi: 10.1097/CCM.0000000000002554.

525. Chen Z, Jia Q, Liu C. Association of Hyponatremia and Risk of Short- and Long-Term Mortality in Patients with Stroke: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2019 Jun; 28(6): 1674 - 1683. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.021. Epub 2019 Apr 6. PMID: 30967305.

526. Shima S, Niimi Y, Moteki Y, Takahashi O, Sato S, Inoue T, Okada Y. Prognostic Significance of Hyponatremia in Acute Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2020; 49(5): 531 - 539. doi: 10.1159/000510751. Epub 2020 Oct 5. PMID: 33017822.

527. Cerecedo-Lopez CD, Cantu-Aldana A, Patel NJ, Aziz-Sultan MA, Frerichs KU, Du R. Insulin in the Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. World Neurosurg. 2020 Apr; 136: e514 - e534. doi: 10.1016/j.wneu.2020.01.056. Epub 2020 Jan 16. PMID: 31954893.

528. Schwab S, Spranger M, Schwarz S, Hacke W. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology. 1997 Jun; 48(6): 1608-13. doi: 10.1212/wnl.48.6.1608. PMID: 9191775.

529. Donnan GA, Hommel M, Davis SM, McNeil JJ. Streptokinase in acute ischaemic stroke: Steering Committees of the ASK and MAST-E trials: Australian Streptokinase Trial. Lancet. 1995; 346: 56.

530. The Multicenter Acute Stroke Trial--Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996; 335: 145 - 150.

531. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995; 346: 1509 - 1514.

532. Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Besson G, Leys D, Amarenco P, Bogaert M. Termination of trial of streptokinase in severe acute ischaemic stroke: MAST Study Group. Lancet.1995; 345: 57.

533. von Kummer R, Mori E, Truelsen T, Jensen JS, BA, Fiebach JB, Lovblad KO, Pedraza S, Romero JM, Chabriat H, Chang KC, A, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A, Albers GW; for the DIAS-4 Investigators. Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke). Stroke. 2016; 47: 2880 - 2887. doi: 10.1161/STROKEAHA.116.013715.

534. Albers GW, von Kummer R, Truelsen T, Jensen JK, Ravn GM, BA, Chabriat H, Chang KC, Davalos AE, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A; DIAS-3 Investigators. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet Neurol. 2015; 14: 575 - 584. doi: 10.1016/S1474-4422(15) 00047-2.

535. Deguchi I, Hayashi T, Neki H, et al. Carotid Artery Stenting for Acute Ischemic Stroke Patients after Intravenous Recombinant Tissue Plasminogen Activator Treatment. Intern Med. 2016; 55(19): 2869 - 2872. doi: 10.2169/internalmedicine.55.7038.

536. Villablanca JP, Rodriguez FJ, Stockman T, et al. MDCT angiography for detection and quantification of small intracranial arteries: comparison with conventional catheter angiography. AJR Am J Roentgenol 2007; 188; 593 - 602.

537. Bartlett ES, Walters TD, Symons SP, Fox AJ. Diagnosting carotid stenosis near-occlusion by using CT angiography. AJNR Am J Neuroradiol 2006; 27: 632 - 637.

538. Burton K.R., Dhanoa D., Aviv R.I., Moody A.R., Kapral M.K., Laupacis A. Perfusion CT for selecting patients with acute ischemic stroke for intravenous thrombolytic therapy. Radiology. 2015 Jan; 274(1): 103-14. doi: 10.1148/radiol.14140728. Epub 2014 Sep 19.

539. Tsivgoulis G., Katsanos A.H., Schellinger P.D., M., Caso V., Palaiodimou L., Magoufis G., Arthur A., Fischer U., Alexandrov A.V. Advanced Neuroimaging in Stroke Patient Selection for Mechanical Thrombectomy. Meta-Analysis. Stroke. 2018 Dec; 49(12): 3067 - 3070. doi: 10.1161/STROKEAHA.118.022540.

540. Wardlaw J.M., Chappell F.M., Best J.J. et al. Non-invasive imaging compared with intraarterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006; 367; 1503 - 1512.

541. Caplan L.R., Hennerici M. Impaired clearenceof emboli (washout) is an important link between hypoperfusion, embolism and ischemic stroke.//Arh.Neurol., 1998. - V.55. - P. 1475 - 1482.

542. Rasumovsky A.Y., Oppenheimer S.M. TCD in Acute Stroke// Stroke. 2000. Vol. 31. P/231.

543. G, Nagy Z, Balkay L, Boros I, Emri M, Lehel S, T, T, Szak ll S. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. J Neurol Sci. 2005 Mar 15; 229 - 230: 275-84. doi: 10.1016/j.jns.2004.11.053. Epub 2005 Jan 8. PMID: 15760651.

544. Zhang C, Yan C. Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases. J Cell Immunol. 2020; 2(5): 211 - 219. doi: 10.33696/immunology.2.045.

545. Ziganshina LE, Abakumova T, Hoyle CH. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2020 Jul 14; 7(7): CD007026. doi: 10.1002/14651858.CD007026.pub6. PMID: 32662068; PMCID: PMC7387239.

546. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012 Mar; 43(3): 630-6. doi: 10.1161/STROKEAHA.111.628537. Epub 2012 Jan 26. PMID: 22282884. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2020 Jul 14; 7(7): CD007026. doi: 10.1002/14651858.CD007026.pub6. PMID: 32662068; PMCID: PMC7387239

547. AJ, Valli C, CE, I, J, Bonfill Cosp X. Citicoline for treating people with acute ischemic stroke. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD013066. DOI: 10.1002/14651858.CD013066.pub2. Accessed 26 May 2021.

548. Mohan Rajwani K, Crocker M, Moynihan B. Decompressive craniectomy for the treatment of malignant middle cerebral artery infarction. Br J Neurosurg. 2017 Aug; 31(4): 401 - 409. doi: 10.1080/02688697.2017.1329518. Epub 2017 Jun 12. PMID: 28604106.

549. Stahl S.M. Prescriber"s guide: Stahl"s essential psychopharmacology. - Cambridge University Press, 2020.

550. Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, P, Olsson JE, Samuelsson M, A, Varelius R, Asberg M, B. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005 Jun; 66(6): 708-16. doi: 10.4088/jcp.v66n0606. PMID: 15960563.

551. Cipriani A., Furukawa T.A., Salanti G. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple treatments meta-analysis. Lancet 2009; 373: 746-58].

552. Jorge R.E., Acion L., Moser D. et al. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67: 187-96.

553. Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: A systematic review and meta-analysis. J Rehabil Med. 2018 Sep 28; 50(9): 769 - 778. doi: 10.2340/16501977-2384. PMID: 30184240.

554. Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J Stroke. 2013 Oct; 8(7): 545-59. doi: 10.1111/j.1747-4949.2012.00906.x. Epub 2012 Sep 27. PMID: 23013268.

555. Lenze EJ, Rollman BL, Shear MK, Dew MA, Pollock BG, Ciliberti C, Costantino M, Snyder S, Shi P, Spitznagel E, Andreescu C, Butters MA, Reynolds CF 3rd. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA. 2009 Jan 21; 301(3): 295 - 303. doi: 10.1001/jama.2008.977. PMID: 19155456; PMCID: PMC2840403.

556. Lannin NA, Cusick A, McCluskey A, Herbert RD. Effects of splinting on wrist contracture after stroke: a randomized controlled trial. Stroke. 2007; 38: 111 - 116. doi: 10.1161/01.STR.0000251722.77088.12. LinkGoogleScholar

557. Бушкова Ю.В., Казакова З.Д., Стаховская Л.В., Иванова Г.Е., Фролов А.А. Возможности функционального восстановления верхней конечности у пациентов после инсульта с применением нейрокомпьютерного интерфейса мозг-компьютер-экзоскелет кисти с многоканальной биологической обратной связью. Фарматека. 2018. N 14 (367). С. 32 - 38.

558. Ang, K.K., K.S. Chua, K.S. Phua, C. Wang, Z.Y. Chin, C.W. Kuah, W. Low, C. Guan, A Randomized Controlled Trial of EEG-Based Motor Imagery Brain-Computer Interface Robotic Rehabilitation for Stroke. Clinical EEG and neuroscience, 2015. 46(4): p. 310-20.

559. Фролов А.А., Мокиенко О.А., Люкманов Р.Х., Черникова Л.А., Котов С.В., Турбина Л.Г., Бобров П.Д., Бирюкова Е.В., Кондур А.А., Иванова Г.Е., Старицын А.Н., Бушкова Ю.В., Джалагония И.З., Курганская М.Е., Павлова О.Г., Будилин С.Ю., Азиатская Г.А., Хижникова А.Е., Червяков А.В., Лукьянов А.Л. и др. Предварительные результаты контролируемого исследования эффективности технологии ИМК-экзоскелет при постинсультном парезе руки. Вестник Российского государственного медицинского университета. 2016. N 2. С. 17 - 25.

560. Carvalho R., Dias N., Cerqueira J.J. Brain-machine interface of upper limb recovery in stroke patients rehabilitation: A systematic review // doi: 10.1002/pri.1764.Apl 2019.

561. The validity and reliability of a 6-Metre Timed Walk for the functional assessment of patients with stroke. Physiother Theory Pract. 2010 May; 26(4): 251-5. Doi: 10.3109/09593980903015235.

562. Dobkin BH, Plummer-D'Amato P, Elashoff R, Lee J, SIRROWS Group. International randomized clinical trial, stroke inpatient rehabilitation with reinforcement of walking speed (SIRROWS), improves outcomes. Neurorehabil. Neural Repair 2010; 24: 235 - 242.

563. Bes A, Eyssette M, Pierrot-Deseilligny E, et al. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia. Curr Med Res Opin. 1988; 10: 709 - 718.

564. Pratzel H.G., Alken R.-G., Ramm S. Efficacy and tolerance of repeated doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial // Pain. 1996; 67: 417 - 425.

565. Morer C., A. et al. Evaluation of the Feasibility of a Two-Week Course of Aquatic Therapy and Thalassotherapy in a Mild Post-Stroke Population // Int. J. Environ. Res. Public Health 2020, 17(21), 8163; doi.org/10.3390/ijerph17218163.

566. Min Ho Chun, Min Cheol Chang, Sung-Jae Lee The effects of forest therapy on depression and anxiety in patients with chronic stroke //Int J Neurosci. - 2017 Mar; 127(3): 199 - 203, doi: 10.3109/00207454.2016.1170015. Epub 2016 Apr 10.

567. Foley N., Murie-Fernandez M., Speechley M. et al. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin improve gait velocity? A systematic review and meta-analysis. Eur J Neurology 2010; 17(12); 1419-27.

568. Emre M, Leslie GC, Muir C, et al. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud). J Neurol Neurosurg Psychiatry. 1994; 57: 1355 - 1359.

569. Simpson, D.M., J.M. Gracies, S.A. Yablon, R. Barbano, A. Brashear, Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. Journal of neurology, neurosurgery, and psychiatry, 2009. 80(4): p. 380-5.

570. Kinnear BZ, Lannin NA, Cusick A, Harvey LA, Rawicki B. Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review. Phys Ther. 2014 Nov; 94(11): 1569-81. doi: 10.2522/ptj.20130408. Epub 2014 Jul 24. PMID: 25060957.

571. Esquenazi A, Bavikatte G, Bandari DS, Jost WH, Munin MC, Tang SFT, Largent J, Adams AM, Zuzek A, Francisco GE. Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity. PM R. 2020 Nov 5. doi: 10.1002/pmrj.12517. Epub ahead of print. PMID: 33151636.

572. Pikula A, Beiser AS, Wang J, Himali JJ, Kelly-Hayes M, Kase CS, Yang Q, Seshadri S, Wolf PA. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study. Neurology. 2015; 84(5): 472 - 479 ttps://doi.org/10.1212/WNL.0000000000001202.

573. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine. 2006; 355(6): 549 - 559. https://doi.org/10.1056/NEJMoa061894.

574. Flint AC, Conell C, Ren X, Kamel H, Chan SL, Rao VA, Johnston SC. Statin adherence is associated with reduced recurrent stroke risk in patients with or without atrial fibrillation. Stroke. 2017; 48(7): 1788 - 1794. https://doi.org/10.1161/STROKEAHA.117.017343.

575. Zhao Z, Du S, Shen S, Luo P, Ding S, Wang G, Wang L. Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis. Medicine. 2019; 98(6): e14400. https://doi.org/10.1097/MD.0000000000014400.

576. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen M-R, Tokgozoglu L, Wiklund O. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2019. https://doi.org/10.1093/eurheartj/ehz455.

577. Greving J. P. et al. Antiplatelet therapy after noncardioembolic stroke: an individual patient data network meta-analysis //Stroke. - 2019. - T. 50. - N. 7. - С. 1812 - 1818.

578. Liu, X., Xu, Z.-X., Yu, P., Yuan, P., & Zhu, W.-G. (2020). Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies. Cardiovascular Drugs and Therapy. doi: 10.1007/s10557-020-06961-7.

579. Sterne J.A. C. et al. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis //Health Technology Assessment Volume. - 2017. - T. 21. - N. 9.

580. Amarenco P., Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention //The Lancet Neurology. - 2009. - T. 8. - N. 5. - C. 453 - 463.

581. Cai X. et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis //bmj. - 2020. - T. 370.

582. Rudd M. et al. A systematic review of stroke recognition instruments in hospital and prehospital settings //Emergency Medicine Journal. - 2016. - T. 33. - N. 11. - C. 818 - 822.

583. Sprigg N. et al. A systematic review of delays in seeking medical attention after transient ischaemic attack //Journal of Neurology, Neurosurgery & Psychiatry. - 2009. - T. 80. - N. 8. - C. 871 - 875.

584. Huang Q. et al. Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: a meta-analysis //Medicine. - 2018. - T. 97. - N. 25.

585. Stroke Unit Trialists" Collaboration et al. Organised inpatient (stroke unit) care for stroke //Cochrane Database of systematic reviews. - 2013. - N. 9.

586. Spokoyny I. et al. Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network //Journal of Stroke and Cerebrovascular Diseases. - 2014. - T. 23. - N. 3. - C. 511 - 515.

587. Man S, Xian Y, Holmes DN, et al. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. JAMA. 2020; 323(21): 2170 - 2184. doi: 10.1001/jama.2020.5697.

588. Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; THALES Investigators. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020 Jul 16; 383(3): 207 - 217. doi: 10.1056/NEJMoa1916870. PMID:

589. Chun HY, Whiteley WN, Dennis MS, Mead GE, Carson AJ. Anxiety After Stroke: The Importance of Subtyping. Stroke. 2018 Mar; 49(3): 556 - 564. doi: 10.1161/STROKEAHA.117.020078. Epub 2018 Feb 6. PMID: 29437982; PMCID: PMC5839706.

590. Galyaev I. Y. Alternating pneumocompression-effective physiotherapeutic method for the prevention of venous thromboembolic complications in patients of medium and high risk in the acute period of the stroke //Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. - 2018. - T. 95. - N. 1. - C. 14 - 19.

591. Krukowska J. et al. The influence of NDT-Bobath and PNF methods on the field support and total path length measure foot pressure (COP) in patients after stroke //Neurologia i neurochirurgia polska. - 2016. - T. 50. - N. 6. - C. 449 - 454.

592. Thieme H. et al. Mirror therapy for improving motor function after stroke //Cochrane database of systematic reviews. - 2018. - N. 7.

593. Veldema, J., & Jansen, P. (2020). Resistance training in stroke rehabilitation: systematic review and meta-analysis. Clinical Rehabilitation, 026921552093296. doi: 10.1177/0269215520932964

594. Супонева Н.А., Юсупова Д.Г., Зимин А.А., Зайцев А.Б., Яцко К.А., Мельченко Д.А., Римкевичус А.А., Жирова Е.С., Таратухина А.С., Ризванова А.С., Гатина Г.А., Калинкина М.Э., Пирадов М.А., Берг К. Валидация Шкалы баланса Берг в России. Неврология, нейропсихиатрия, психосоматика, 2021; 13(3): 12 - 18. DOI: 10.14412/2074-2711-2021-3-12-18.

595. Blum, Lisa; Korner-Bitensky, Nicol (May 2008). "Usefulness of the Berg Balance Scale in Stroke Rehabilitation: A Systematic Review". Physical Therapy. 88 (5): 559 - 566. doi: 10.2522/ptj.20070205. PMID 18292215.

596. Downs S, Marquez J, Chiarelli P (2013). "The Berg Balance Scale has high intra- and inter-rater reliability but absolute reliability varies across the scale: a systematic review". J Physiotherapy. 59 (2): 93 - 99. doi: 10.1016/s1836-9553(13)70161-9. PMID 23663794.

597. Berg KO, Wood-Dauphinee SL, Williams JI, Maki B (1992). "Measuring balance in the elderly: validation of an instrument". Can J Public Health. 83 Suppl 2: S7-11. PMID 1468055.

598. Stevenson TJ (2001). "Detecting change in patients with stroke using the Berg Balance Scale" (PDF). Aust J Physiother. 47 (1): 29 - 38. doi: 10.1016/s0004-9514(14)60296-8. PMID 11552860. Archived from the original (PDF) on 2015-05-26.

599. Воловец С.А., Сергеенко Е.Ю., Даринская Л.Ю., Поляев Б.А., Яшинина Ю.А., Исаева М.А., Житарева И.В., Лобов А.Н., Панова Т.И. Современный подход к восстановлению постурального баланса у пациентов с последствиями острого нарушения мозгового кровообращения. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2018; 95(2): 4 - 9. https://doi.org/10.17116/kurort20189524-9.

600. Patla A, Shumway-Cook A. "Dimensions of mobility: defining the complexity and difficulty associated with community mobility." J Aging Phys Act. 1999; 7: 7 - 19.

601. Jonsdottir J., Cattaneo D. "Reliability and Validity of the Dynamic Gait Index in Persons With Chronic Stroke". Archives of Physical Medicine and Rehabilitation 88(11): 1410-5. 2007. DOI: 10.1016/j.apmr.2007.08.109.

602. Shumway-Cook A., Taylor C.S., Matsuda P.N., Studer M.T., Whetten B.K. "Expanding the scoring system for the Dynamic Gait Index." Phys Ther. 2013 Nov; 93(11): 1493-506. doi: 10.2522/ptj.20130035. Epub 2013 Jun 27.

603. Shumway-Cook A., Taylor C.S., Matsuda P.N. "Investigating the validity of the environmental framework underlying the original and modified Dynamic Gait Index." Phys Ther. 2015 Jun; 95(6): 864-70. doi: 10.2522/ptj.20140047. Epub 2014 Dec 18.